USBIOMAX

Products
Catalog-Num Product Name Quantity Price Supplier Category
Catalog-Num Product Name Quantity Price Supplier
AC451 Multiple organ condyloma acuminatum tissue array, 45 cases_45 cores 331-Eur US Biomax tissue
AC451 Multiple organ condyloma acuminatum tissue array, 45 cases_45 cores; ihc Anti-Human Papilloma Virus (HPV) confimed 210-Eur US Biomax tissue
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores 456-Eur US Biomax tissue
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
AG801 Adrenal tumor tissue array, 80 cases_80 cores 266-Eur US Biomax tissue
AG801 Adrenal tumor tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
AMS541 Mouse(FBV strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores 225-Eur US Biomax tissue
AMS541 Mouse(FBV strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores; ihc H&E 238-Eur US Biomax tissue
AMS542 Mouse(KM strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores 225-Eur US Biomax tissue
AMS542 Mouse(KM strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores; ihc H&E 238-Eur US Biomax tissue
AMS543 Skin squamous cell carcinoma (SCC) tissue array, 80 cases_80 cores, no overlaps with SK801; ihc Anti-Cytokeratin (High MW) confirmed 215-Eur US Biomax tissue
AMS544 Mouse normal tissue array, covering 22 organ_anatomic sites, 3 cases_54 cores 225-Eur US Biomax tissue
AMS544 Mouse normal tissue array, covering 22 organ_anatomic sites, 3 cases_54 cores; ihc H&E 238-Eur US Biomax tissue
ART661 Rat(Wistar strain) normal tissue array, covering all major organs, non-overlapping with ART662, 22 cases_66 cores 225-Eur US Biomax tissue
ART661 Rat(Wistar strain) normal tissue array, covering all major organs, non-overlapping with ART662, 22 cases_66 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 238-Eur US Biomax tissue
ASM221 Cyno monkey normal tissue array, 22 cases_22 cores 225-Eur US Biomax tissue
ASM221 Cyno monkey normal tissue array, 22 cases_22 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 238-Eur US Biomax tissue
BB01011 Gastric ulcer tissue array, 14 cases _24 cores 160-Eur US Biomax tissue
BB01011 Gastric ulcer tissue array, 14 cases _24 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC000110 Colorectal cancer tissue array, 85 cases_170 cores 397-Eur US Biomax recombinant
BC000110 Colorectal cancer tissue array, 85 cases_170 cores; ihc Anti-Actin confirmed 382-Eur US Biomax recombinant
BC000111 Multiple organ cancer tissue array, 39 cases_39 cores 189-Eur US Biomax tissue
BC000111 Multiple organ cancer tissue array, 39 cases_39 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC000119 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores 456-Eur US Biomax tissue
BC000119 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BC00012 Multiple organ diseased tissue array, 30 cases_60 cores, replaced by MC801 160-Eur US Biomax tissue
BC00012 Multiple organ diseased tissue array, 30 cases_60 cores, replaced by MC801; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC000120 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores 456-Eur US Biomax tissue
BC000120 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BC00014 Multiple organ diseased tissue array, 63 cases_63 cores, replaced by MC631 160-Eur US Biomax tissue
BC00014 Multiple organ diseased tissue array, 63 cases_63 cores, replaced by MC631; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC00016 Multiple organ diseased tissues, 54 cases_54 cores, replaced by MC541 160-Eur US Biomax tissue
BC00016 Multiple organ diseased tissues, 54 cases_54 cores, replaced by MC541; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases_63 cores 231-Eur US Biomax tissue
BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases_60 cores 231-Eur US Biomax tissue
BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases_60 cores; ihc Anti-SMA confirmed 267-Eur US Biomax tissue
BC001111 Multiple organ normal and diseased tissue array, 58 cases_60 cores, replaced by MCN601 231-Eur US Biomax tissue
BC001111 Multiple organ normal and diseased tissue array, 58 cases_60 cores, replaced by MCN601; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC001113 Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases_50 cores (previously cat# ES501) 189-Eur US Biomax tissue
BC001113 Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases_50 cores (previously cat# ES501); ihc Anti-Cytokeratin (Low MW) confirmed Certified pathologist c 267-Eur US Biomax tissue
BC00112 Multiple organ paired normal and cancer (8 types) tissue array, 48 cases_48 cores 160-Eur US Biomax tissue
BC00112 Multiple organ paired normal and cancer (8 types) tissue array, 48 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases_175 cores 485-Eur US Biomax tissue
BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases_175 cores 397-Eur US Biomax tissue
BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases_175 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC00113 Multiple organs tumor and normal tissue, 48 cases_48 cores 189-Eur US Biomax tissue
BC00113 Multiple organs tumor and normal tissue, 48 cases_48 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BC001130 Pancreatic carcinoma and multi-organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases_121 cores 278-Eur US Biomax tissue
BC001130 Pancreatic carcinoma and multi-organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases_121 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases_150 cores 397-Eur US Biomax tissue
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases_150 cores; ihc Anti-Actin confirmed 382-Eur US Biomax tissue
BC00114 Multiple organ normal and diseased tissue array, 36 cases_60 cores 231-Eur US Biomax tissue
BC00114 Multiple organ normal and diseased tissue array, 36 cases_60 cores; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC00115 Multiple organ normal and diseased tissue array, 44 cases_64 cores, replaced by MC802 231-Eur US Biomax tissue
BC00115 Multiple organ normal and diseased tissue array, 44 cases_64 cores, replaced by MC802; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC00116 Carcinoma with adjacent-tissue combined panel tissue array, 44 cases_48 cores 231-Eur US Biomax tissue
BC00116 Carcinoma with adjacent-tissue combined panel tissue array, 44 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC00119 Multiple organ diseased tissue array, 32 cases_32 cores, replaced by MC483 160-Eur US Biomax tissue
BC00119 Multiple organ diseased tissue array, 32 cases_32 cores, replaced by MC483; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases_43 cores 160-Eur US Biomax tissue
BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases_43 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases_18 cores 231-Eur US Biomax tissue
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases_18 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BC01011 Stomach carcinoma (multi-tissue combined panel) tissue array, 24 cases _72 cores, replaced by ST721 160-Eur US Biomax tissue
BC01011 Stomach carcinoma (multi-tissue combined panel) tissue array, 24 cases _72 cores, replaced by ST721; ihc Anti-Cytokeratin (CK) confirmed 162-Eur US Biomax tissue
BC01014 Stomach carcinoma tissue array (multi-tissue combined panel), 71 cases _72 cores, replaced by ST807 231-Eur US Biomax tissue
BC01014 Stomach carcinoma tissue array (multi-tissue combined panel), 71 cases _72 cores, replaced by ST807; ihc CgA confirmed 267-Eur US Biomax tissue
BC01022 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores 160-Eur US Biomax tissue
BC01022 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC01023 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores 160-Eur US Biomax tissue
BC01023 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BC01024 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores 160-Eur US Biomax tissue
BC01024 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores, replaced by ST722; ihc Anti-Cytokeratin (CK) confirmed 162-Eur US Biomax tissue
BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores 160-Eur US Biomax recombinant
BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores, replaced by BC01071a; ihc Anti-P53 confirmed 185-Eur US Biomax recombinant
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_48 cores, replacing BC01071; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BC01081 Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores 456-Eur US Biomax recombinant
BC01081 Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores; ihc Anti-EMA confirmed 487-Eur US Biomax recombinant
BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases_100 cores 231-Eur US Biomax tissue
BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases_100 cores, replaced by ST1004; ihc Anti-Cytokeratin (CK) confi 258-Eur US Biomax tissue
BC02011 Multiple esophageal cancer tissue array, 69 cases_72 cores 160-Eur US Biomax tissue
BC02011 Multiple esophageal cancer tissue array, 69 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC02012 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores 160-Eur US Biomax tissue
BC02012 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC02013 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores 160-Eur US Biomax tissue
BC02013 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BC02021 Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores 160-Eur US Biomax tissue
BC02021 Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC02022 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores 160-Eur US Biomax tissue
BC02022 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC02023 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54cores, replaced by ES722 160-Eur US Biomax tissue
BC02023 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54cores, replaced by ES722 ; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC02111 Esophagus adenocarcinoma and normal tissue array, 23 cases_80 cores 189-Eur US Biomax tissue
BC02111 Esophageal adenocarcinoma tissue array with matched normal adjacent tissue, 21 cases_80 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores 266-Eur US Biomax tissue
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV8010 160-Eur US Biomax tissue
BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV8010; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC03013 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV723 160-Eur US Biomax tissue
BC03013 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV723; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases_63 cores, replaced by LV803 231-Eur US Biomax tissue
BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases_63 cores, replaced by LV803; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases_70 cores 231-Eur US Biomax tissue
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases_70 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores 456-Eur US Biomax tissue
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores 278-Eur US Biomax tissue
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases_100 cores 266-Eur US Biomax tissue
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC04011 Lung cancer tissue array, including pathology grade, 23 cases_63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC04012 Lung carcinoma (multi-tissue combined panel) tissue array, 68 cases_72 cores 160-Eur US Biomax tissue
BC04012 Lung carcinoma (multi-tissue combined panel) tissue array, 68 cases_72 cores, replaced by BC04016; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC04013 Non-small cell lung carcinoma tissue array, 63 cases_63 core, replaced by LC806 160-Eur US Biomax tissue
BC04013 Non-small cell lung carcinoma tissue array, 63 cases_63 core, replaced by LC806; ihc CK confirmed 185-Eur US Biomax tissue
BC04014 Non-small cell lung carcinoma (NSCLC) tissue array, 63 cases_63 cores, replaced by LC807 160-Eur US Biomax tissue
BC04014 Non-small cell lung carcinoma (NSCLC) tissue array, 63 cases_63 cores, replaced by LC807; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BC04015 Lung carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores 160-Eur US Biomax tissue
BC04015 Lung carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 162-Eur US Biomax tissue
BC04016 Lung carcinoma tissue array, 72 cases_72 cores, replaced by LC726 160-Eur US Biomax tissue
BC04016 Lung carcinoma tissue array, 72 cases_72 cores, replaced by LC726; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC04021 Lung carcinoma (multi-tissue combined panel) tissue array, 72 cases _72 cores 160-Eur US Biomax tissue
BC04021 Lung carcinoma (multi-tissue combined panel) tissue array, 72 cases _72 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC04022 Non-small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases_54 cores 160-Eur US Biomax tissue
BC04022 Non-small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases_54 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores 456-Eur US Biomax tissue
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores 278-Eur US Biomax tissue
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores, replaced by BC041115a; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases_120 cores, replacing BC041115; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores 231-Eur US Biomax tissue
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases_40 cores, replaced by BC04119b 231-Eur US Biomax tissue
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases_40 cores, replaced by BC04119b; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases_40 cores, replacing BC04119 336-Eur US Biomax tissue
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases_40 cores, replacing BC04119 278-Eur US Biomax tissue
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases_40 cores, replacing BC04119; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases_80 cores 266-Eur US Biomax tissue
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC05011 Multiple types of colon carcinoma tissue array, 72 cases_72 cores, replaced by CO804 231-Eur US Biomax tissue
BC05011 Multiple types of colon carcinoma tissue array, 72 cases_72 cores, replaced by CO804; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC050112 Colon metastatic carcinoma tissue array, 23 cases_63 cores, replaced by CO726 231-Eur US Biomax tissue
BC050112 Colon metastatic carcinoma tissue array, 23 cases_63 cores, replaced by CO726; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BC05012 Colon carcinoma (multi-tissue combined panel) tissue array, 70 cases_72 cores. 231-Eur US Biomax tissue
BC05012 Colon carcinoma (multi-tissue combined panel) tissue array, 70 cases_72 cores.; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BC05021 Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases_54 cores, no overlapping with BC05022, replaced by CO722 231-Eur US Biomax tissue
BC05021 Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases_54 cores, no overlapping with BC05022, replaced by CO722; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC05022 Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, no overlapping with BC05021 231-Eur US Biomax tissue
BC05022 Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, no overlapping with BC05021; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BC05023 Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases_54 cores 231-Eur US Biomax tissue
BC05023 Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases_54 cores; ihc Anti-Epithelial Membrane Antigen (EMA) confirmed 267-Eur US Biomax tissue
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores 278-Eur US Biomax tissue
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores 456-Eur US Biomax tissue
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases_69 cores, replaced by CO702 231-Eur US Biomax tissue
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases_69 cores, replaced by CO702; ihc Anti-Cytokeratin (Low-MW) conf 258-Eur US Biomax tissue
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores 266-Eur US Biomax tissue
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replaced by BC05118a; ihc Anti-actin confirmed Certified pathologist code 296-Eur US Biomax tissue
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BC05118; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases_72 cores 321-Eur US Biomax recombinant
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases_72 cores 266-Eur US Biomax recombinant
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases_72 cores; ihc Anti-Actin confirmed 258-Eur US Biomax recombinant
BC06011 Rectum carcinoma (multi-tissue combined panel) tissue array, 71 cases_72 cores 160-Eur US Biomax recombinant
BC06011 Rectum carcinoma (multi-tissue combined panel) tissue array, 71 cases_72 cores; ihc Anti-CEA confirmed 185-Eur US Biomax recombinant
BC06022 Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, replaced by RE722 160-Eur US Biomax recombinant
BC06022 Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, replaced by RE722; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax recombinant
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases_80 cores 321-Eur US Biomax tissue
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases_80 cores 266-Eur US Biomax tissue
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BC07011 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores, replaced by BC07013 160-Eur US Biomax tissue
BC07011 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores, replaced by BC07013; ihc Anti-EMA confirmed 185-Eur US Biomax tissue
BC07012 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores, replaced by BC07015 160-Eur US Biomax tissue
BC07012 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores, replaced by BC07015; ihc Anti-EMA confirmed 185-Eur US Biomax tissue
BC07013 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores, replacing BC07011 160-Eur US Biomax tissue
BC07013 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores, replacing BC07011; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC07014 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores 160-Eur US Biomax tissue
BC07014 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC07014; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases_72 cores, replacing BC07012 231-Eur US Biomax tissue
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases_72 cores, replacing BC07012; ihc Anti-Cytokeratin (High MW) confirmed 267-Eur US Biomax tissue
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases_200 cores 558-Eur US Biomax tissue
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases_200 cores 456-Eur US Biomax tissue
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases_200 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases_120 cores 321-Eur US Biomax tissue
BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases_120 cores 266-Eur US Biomax tissue
BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases_120 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC08013 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014 160-Eur US Biomax tissue
BC08013 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014; ihc Anti-ER confirmed 185-Eur US Biomax tissue
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018 160-Eur US Biomax tissue
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BC08015 Breast carcinoma (multi-tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728 160-Eur US Biomax tissue
BC08015 Breast carcinoma (multi-tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC08016 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803 160-Eur US Biomax tissue
BC08016 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021 160-Eur US Biomax tissue
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021; ihc Anti-ER confirmed 185-Eur US Biomax tissue
BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores 231-Eur US Biomax tissue
BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BC08032 Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores 231-Eur US Biomax tissue
BC08032 Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120 278-Eur US Biomax tissue
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores 278-Eur US Biomax tissue
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115 266-Eur US Biomax tissue
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores 321-Eur US Biomax tissue
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores 266-Eur US Biomax tissue
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BC09012 Endometrial carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores 231-Eur US Biomax tissue
BC09012 Endometrial carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC10021 Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases_72 cores 231-Eur US Biomax tissue
BC10021 Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC10025 Cervical cancer and normal tissue array, 54 cases_54 cores 231-Eur US Biomax tissue
BC10025 Cervical cancer and normal tissue array, 54 cases_54 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC11011 Ovarian carcinoma (multi-tissue combined panel) tissue array (replaced by OV802), 70 cases_72 cores 160-Eur US Biomax tissue
BC11011 Ovarian carcinoma (multi-tissue combined panel) tissue array (replaced by OV802), 70 cases_72 cores; ihc Anti-EMA confirmed 185-Eur US Biomax tissue
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases_72 cores, replacing BC11012 231-Eur US Biomax tissue
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases_72 cores, replacing BC11012; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BC11012 Ovarian carcinoma (multi-tissue combined panel) tissue array, 70 cases_72 cores 160-Eur US Biomax tissue
BC11012 Ovarian carcinoma (multi-tissue combined panel) tissue array, 70 cases_72 cores, replaced by BC11012a; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC11012; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores 231-Eur US Biomax tissue
BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores 231-Eur US Biomax tissue
BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores, replaced by OV701; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases_100 cores 321-Eur US Biomax tissue
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases_100 cores 266-Eur US Biomax tissue
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases_100 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing BC12011; ihc Anti-Actin confirmed 162-Eur US Biomax tissue
BC12012 Bladder carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802 231-Eur US Biomax tissue
BC12012 Bladder carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC14012 Pancreatic cancer (multi-tissue combined panel), 24 cases_63 cores, replaced by PA721 231-Eur US Biomax tissue
BC14012 Pancreatic cancer (multi-tissue combined panel), 24 cases_63 cores, replaced by PA721; ihc Anti-Cytokeration (CK) confirmed 267-Eur US Biomax tissue
BC15012 Thyroid carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores 231-Eur US Biomax tissue
BC15012 Thyroid carcinoma (multi-tissue combined panel) tissue array, 23 cases_63 cores; ihc Anti-Thyroglobulin (TG) antibody confirmed 267-Eur US Biomax tissue
BC17012 Medulloblastoma of brain tissue array, 100 cases_100 cores 277-Eur US Biomax tissue
BC17012 Medulloblastoma of brain tissue array, 100 cases_100 cores 231-Eur US Biomax tissue
BC17012 Medulloblastoma of brain tissue array, 20 cases_60 cores; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores 321-Eur US Biomax tissue
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores 266-Eur US Biomax tissue
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC19012 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases_63 cores, replaced by PR808 231-Eur US Biomax tissue
BC19012 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases_63 cores, replaced by PR808; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC19013 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases_63 cores 231-Eur US Biomax tissue
BC19013 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases_63 cores; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC19014 Prostate carcinoma tissue array, 31 cases_63 cores 231-Eur US Biomax tissue
BC19014 Prostate carcinoma tissue array, 31 cases_63 cores; ihc Anti-PTEN confirmed 267-Eur US Biomax tissue
BC19015 Prostate carcinoma tissue array, 9 cases_27 cores 160-Eur US Biomax tissue
BC19015 Prostate carcinoma tissue array, 9 cases_27 cores; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BC19017 Prostate carcinoma tissue array, 33 cases_63 cores, replaced by PR809 160-Eur US Biomax tissue
BC19017 Prostate carcinoma tissue array, 33 cases_63 cores, replaced by PR809; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC19019 Prostate cancer and hyperplasia tissue array, 33 cases_63 cores, replacing BC19011 231-Eur US Biomax tissue
BC19019 Prostate cancer and hyperplasia tissue array, 33 cases_63 cores, replacing BC19011; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores 266-Eur US Biomax tissue
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases_30 cores 160-Eur US Biomax tissue
BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases_30 cores; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC21011 Skin malignant tumor tissue array, 78 cases_78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 231-Eur US Biomax tissue
BC21011 Skin malignant tumor tissue array, 78 cases_78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BC21014 Skin malignant tumor tissue array, 78 cases_78 cores, replacing BC21011 231-Eur US Biomax tissue
BC21014 Skin malignant tumor tissue array, 78 cases_78 cores, replacing BC21011; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC23011 Testis tumor combination, 24 cases_72 cores 231-Eur US Biomax assays
BC23011 Testis tumor combination, 24 cases_72 cores; ihc Anti-Actin confirmed 267-Eur US Biomax assays
BC23012 Testis tumor tissue array, 23 cases_63 cores 231-Eur US Biomax assays
BC23012 Testis tumor tissue array, 23 cases_63 cores; ihc Anti-LCA confirmed 267-Eur US Biomax assays
BC24011 Soft tissue tumor (multi-tissue combined panel) tissue array, 63 cases_63 cores 231-Eur US Biomax tissue
BC24011 Soft tissue tumor (multi-tissue combined panel) tissue array, 63 cases_63 cores; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BC24021 Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases_75 cores 231-Eur US Biomax tissue
BC24021 Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases_75 cores, replaced by SO751; ihc Anti-Des confirmed 267-Eur US Biomax tissue
BC27011 Multiple organs, diseased tissue array of oral cavity, 47 cases_48 cores 189-Eur US Biomax tissue
BC27011 Multiple organs, diseased tissue array of oral cavity, 47 cases_48 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC30011 Heart tissue array, 13 cases_34 cores, replaced by BC30013 231-Eur US Biomax tissue
BC30011 Heart tissue array, 13 cases_34 cores, replaced by BC30013; ihc Anti-Vimentin (Vim) confirmed 267-Eur US Biomax tissue
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases_36 cores 231-Eur US Biomax tissue
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases_36 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases_63 cores 160-Eur US Biomax tissue
BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases_63 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases_72 cores, replaced by HN811 160-Eur US Biomax tissue
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases_72 cores, replaced by HN811; ihc Anti-H-CK confirmed 228-Eur US Biomax tissue
BC35111 Retinoblastoma and normal adjacent tissue array, 17 cases_34 cores 189-Eur US Biomax tissue
BC35111 Retinoblastoma and normal adjacent tissue array, 17 cases_34 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases_72 cores 231-Eur US Biomax tissue
BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases_80 cores 231-Eur US Biomax tissue
BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases_96 cores, replaced by BCN963 231-Eur US Biomax elisa
BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases_96 cores, replaced by BCN963; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax elisa
BCN962 Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases_96 cores 231-Eur US Biomax elisa
BCN962 Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases_96 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax elisa
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases_96 cores, replacing BCN961 266-Eur US Biomax elisa
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases_96 cores, replaced by BCN963a; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases_96 cores, replacing BCN963; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
BE01014 Multiple organ, normal fetus tissue array, 26 cases_78 cores 189-Eur US Biomax tissue
BE01014 Multiple organ, normal fetus tissue array, 26 cases_78 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BE01015 Multiple organ, normal fetus tissue array, 50 cases_50 cores 189-Eur US Biomax tissue
BE01015 Multiple organ, normal fetus tissue array, 50 cases_50 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 266-Eur US Biomax tissue
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores 266-Eur US Biomax tissue
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BL1921 Mid-advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
BL1921 Mid-advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 429-Eur US Biomax elisa
BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases_208 cores) with grade and stage data 456-Eur US Biomax tissue
BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases_208 cores) with grade and stage data; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BL2081 Bladder cancer high density tissue array, 203 cases_208 cores 456-Eur US Biomax tissue
BL2081 Bladder cancer high density tissue array, 203 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores 456-Eur US Biomax tissue
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BL241 Bladder cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores 88-Eur US Biomax tissue
BL241 Bladder cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax tissue
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores 189-Eur US Biomax tissue
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data 100-Eur US Biomax tissue
BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data; ihc Anti-Actin confirmed 114-Eur US Biomax tissue
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data 189-Eur US Biomax tissue
BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores 189-Eur US Biomax tissue
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806 266-Eur US Biomax tissue
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
BL802 Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012 266-Eur US Biomax tissue
BL802 Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores 266-Eur US Biomax tissue
BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores 266-Eur US Biomax tissue
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL805 Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases_80 cores 266-Eur US Biomax tissue
BL805 Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BL801 266-Eur US Biomax tissue
BL806 Bladder cancer tissue array, with matched adjacent normal tissue (NAT), including TNM and pathology grade, 80 cases_80 cores, replacing BL801; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BLC1501 Bladder cancer mid-density tissue array, 75 cases_150 cores 261-Eur US Biomax tissue
BLC1501 Bladder cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 281-Eur US Biomax tissue
BLC241 Bladder cancer tissue array, 12 cases_24 cores 189-Eur US Biomax tissue
BLC241 Bladder cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
BLC661 Bladder cancer tissue array, 33 cases_66 cores 225-Eur US Biomax tissue
BLC661 Bladder cancer tissue array, 33 cases_66 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 238-Eur US Biomax tissue
BM01011 Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases_160 cores, replaced by MO1601 278-Eur US Biomax tissue
BM01011 Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases_160 cores, replaced by MO1601; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BM241 Bone marrow tissue array, 12 cases_24 cores 88-Eur US Biomax tissue
BM241 Bone marrow tissue array, 12 cases_24 cores; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BM481 Normal bone marrow tissue array, 24 cases_48 cores 160-Eur US Biomax tissue
BM481 Normal bone marrow tissue array, 24 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases_48 cores, replaced by BM483 397-Eur US Biomax tissue
BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases_48 cores, replaced by BM483; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482 266-Eur US Biomax tissue
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482; ihc Anti-Actin confirmed 382-Eur US Biomax tissue
BN00011 Multiple organ normal tissue array, 48 cases_48 cores 160-Eur US Biomax tissue
BN00011 Multiple organ normal tissue array, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN00015 Multiple organ normal tissue array, 47 cases_48 cores 160-Eur US Biomax tissue
BN00015 Multiple organ normal tissue array, 47 cases_48 cores; ihc Anti-SMA confirmed 185-Eur US Biomax tissue
BN00112 Multiple organ normal tissue array, 40cases_40 cores, replaced by BN00119 160-Eur US Biomax tissue
BN00112 Multiple organ normal tissue array, 40cases_40 cores, replaced by BN00119; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN00119 Multiple organ normal tissue array, 40 cases_40 cores, replacing BN00112 266-Eur US Biomax tissue
BN00119 Multiple organ normal tissue array, 40 cases_40 cores, replacing BN00112; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BN01011 Normal stomach tissue (multi-sites) array, 21 cases _63 cores, replaced by BN01011b 160-Eur US Biomax tissue
BN01011 Normal stomach tissue (multi-sites) array, 21 cases _63 cores, replaced by BN01011b; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN01011b Normal stomach tissue array, 24 cases_72 cores, replacing BN01011 277-Eur US Biomax tissue
BN01011b Normal stomach tissue array, 24 cases_72 cores, replacing BN01011 231-Eur US Biomax tissue
BN01011b Normal stomach tissue array, 24 cases_72 cores, replacing BN01011; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BN01013 Normal stomach tissue (multi-sites) array, 70 cases _72 cores 160-Eur US Biomax tissue
BN01013 Normal stomach tissue (multi-sites) array, 70 cases _72 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN03011 Normal liver tissue array (multi-sites), 20 cases_63 cores, replaced by LVN801 160-Eur US Biomax tissue
BN03011 Normal liver tissue array (multi-sites), 20 cases_63 cores, replaced by LVN801; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BN04011 Normal lung tissue (multi-sites) tissue array, 22 cases_63 cores, replaced by LC725 160-Eur US Biomax tissue
BN04011 Normal lung tissue (multi-sites) tissue array, 22 cases_63 cores, replaced by LC725; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BN05011 Normal colon tissue (multi-site) array, 23 cases_63 cores, replaced by BN05014 160-Eur US Biomax tissue
BN05011 Normal colon tissue (multi-site) array, 23 cases_63 cores, replaced by BN05014; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases_72 cores, replacing BN05011 160-Eur US Biomax tissue
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases_72 cores, replacing BN05011; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
BN06011 Normal rectum tissue (multi-sites) tissue array, 23 cases_63 cores 160-Eur US Biomax recombinant
BN06011 Normal rectum tissue (multi-sites) tissue array, 23 cases_63 cores; ihc Anti-Actin confirmed 185-Eur US Biomax recombinant
BN06012 Normal rectum tissue (multi-sites) tissue array, 70 cases_72 cores 160-Eur US Biomax recombinant
BN06012 Normal rectum tissue (multi-sites) tissue array, 70 cases_72 cores; ihc Anti-Actin confirmed 185-Eur US Biomax recombinant
BN07011 Normal kidney tissue array (multi-sites), 20 cases_54 cores 160-Eur US Biomax tissue
BN07011 Normal kidney tissue array (multi-sites), 20 cases_54 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BN07012 Normal kidney tissue (multi-sites) tissue array, 70 cases_72 cores, replaced by KD803 160-Eur US Biomax tissue
BN07012 Normal kidney tissue (multi-sites) tissue array, 70 cases_72 cores, replaced by KD803; ihc Anti-Villin confirmed 185-Eur US Biomax tissue
BN08013 Normal breast tissue (multi-sites) array, 71 cases_72 cores, replaced by BRN801 160-Eur US Biomax tissue
BN08013 Normal breast tissue (multi-sites) array, 71 cases_72 cores, replaced by BRN801; ihc anti-Cytokeratin confirmed 185-Eur US Biomax tissue
BN08111 Breast hyperplasia and normal tissue array, 10 cases_30 cores 231-Eur US Biomax tissue
BN08111 Breast hyperplasia and normal tissue array, 10 cases_30 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BN1002 Multiple organ (20) normal tissue array, 100 cases_100 cores, replacing BN1001 266-Eur US Biomax tissue
BN1002 Multiple organ (20) normal tissue array, 100 cases_100 cores, replaced by BN1002a; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BN1002a Multiple organ normal tissue array, 100 cases_100 cores, replacing BN1002; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases_45 cores 189-Eur US Biomax tissue
BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases_45 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN114 Multiple normal human organ tissue array, 48 cases_48 cores 189-Eur US Biomax tissue
BN114 Multiple normal human organ tissue array, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN115 Multiple organ normal tissue array, 46 cases_46 cores 189-Eur US Biomax tissue
BN115 Multiple organ normal tissue array, 46 cases_46 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN116 Multiple organ normal tissue array, 48 cases_48 cores, replaced by BN129 189-Eur US Biomax tissue
BN116 Multiple organ normal tissue array, 48 cases_48 cores, replaced by BN129; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN117 Multiple organ normal tissue array, 45 cases_45 cores 189-Eur US Biomax tissue
BN117 Multiple organ normal tissue array, 45 cases_45 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases_45 cores 231-Eur US Biomax tissue
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases_45 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BN129 Multiple organ adjacent normal tissue array, 48 cases_48 cores, replacing BN116 160-Eur US Biomax tissue
BN129 Multiple organ adjacent normal tissue array, 48 cases_48 cores, replacing BN116; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN242 Multiple normal (12 type) tissue array, 12 cases_24 cores 88-Eur US Biomax tissue
BN242 Multiple normal (12 type) tissue array, 12 cases_24 cores; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BN243 Multiple normal (12 type) tissue array, 12 cases_24 cores, replacing BN241 88-Eur US Biomax tissue
BN243 Multiple normal (12 type) tissue array, 12 cases_24 cores, replaced by BN243a; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax tissue
BN243a Multiple organ normal tissue array, 12 cases_24 cores, replacing BN243; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BN29011 Normal bone marrow tissue array, 60 cases_60 cores 231-Eur US Biomax tissue
BN29011 Normal bone marrow tissue array, 60 cases_60 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases_48 cores 160-Eur US Biomax tissue
BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN482 Normal human tissue microarray from 12 organs from autopsy, 24 cases_48 cores 160-Eur US Biomax tissue
BN482 Normal human tissue microarray from 12 organs from autopsy, 24 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN484 Multiple organ normal tissue array, 24 cases_48 cores 231-Eur US Biomax tissue
BN484 Multiple organ normal tissue array, 24 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BN501 Normal human top 10 organ tissue array, 50 cases_50 cores, replacing BN00012 and BN00013 160-Eur US Biomax tissue
BN501 Normal human top 10 organ tissue array, 50 cases_50 cores, replacing BN00012 and BN00013; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases_102 cores, replacing BN861 266-Eur US Biomax tissue
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases_102 cores, replacing BN861; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores 516-Eur US Biomax tissue
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BO241 Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores 88-Eur US Biomax tissue
BO241 Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores; ihc Anti-Vimentin (Vim) confirmed 105-Eur US Biomax tissue
BO242 Human normal bone tissue array, 12 cases_24 cores, replaced by BO243 100-Eur US Biomax tissue
BO242 Human normal bone tissue array, 12 cases_24 cores, replaced by BO243 ; ihc Anti-Actin confirmed 114-Eur US Biomax tissue
BO243 Human normal bone and osteosarcoma tissue array, 12 cases_24 cores, replaced by BO244 88-Eur US Biomax tissue
BO243 Human normal bone and osteosarcoma tissue array, 12 cases_24 cores, replaced by BO244; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BO244 Human normal bone and osteosarcoma tissue array, 12 cases_24 cores, replacing BO243 100-Eur US Biomax tissue
BO244 Human normal bone and osteosarcoma tissue array, 12 cases_24 cores, replaced by BO244b; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases_24 cores; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BO244b Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases_24 cores, replacing BO244; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data 189-Eur US Biomax tissue
BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
BO601 Bone giant cell tumor tissue array, 30 cases_60 cores 231-Eur US Biomax tissue
BO601 Bone giant cell tumor tissue array, 30 cases_60 cores; ihc Anti-Vimtin confirmed 267-Eur US Biomax tissue
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores 266-Eur US Biomax tissue
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases_160 cores, replacing BR01011 278-Eur US Biomax tissue
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases_160 cores, replacing BR01011; ihc Anti-EMA confirmed 296-Eur US Biomax tissue
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a 88-Eur US Biomax tissue
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores 88-Eur US Biomax tissue
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores 112-Eur US Biomax tissue
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores; ihc Anti-Actin confirmed 114-Eur US Biomax tissue
BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004 314-Eur US Biomax tissue
BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004; ihc Anti-Cytokeratin (Low MW) confirmed 296-Eur US Biomax tissue
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases_100 cores, replacing BR1004 314-Eur US Biomax tissue
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replaced by BR10010a; ihc Anti-Actin confi 296-Eur US Biomax tissue
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replacing BR10010; ihc Anti-Actin confirme 296-Eur US Biomax tissue
BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases _100 cores, with stage and grade information 266-Eur US Biomax tissue
BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases _100 cores, with stage and grade information; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1003 Breast pre-cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data 266-Eur US Biomax tissue
BR1003 Breast pre-cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1004 Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases_100 cores, replaced by BR10010 314-Eur US Biomax tissue
BR1004 Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases_100 cores, replaced by BR10010; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1005 Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004 314-Eur US Biomax
BR1005 Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004, replaced by BR1005a; ihc Anti-Actin confirmed 296-Eur US Biomax
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BR1005; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores 266-Eur US Biomax tissue
BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 266-Eur US Biomax tissue
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212 266-Eur US Biomax tissue
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores 266-Eur US Biomax tissue
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1502 Breast cancer mid-density tissue array, wiht AR_ER_PR_Her-2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503 278-Eur US Biomax tissue
BR1502 Breast cancer mid-density tissue array, wiht AR_ER_PR_Her-2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503; ihc Anti-Vimentin_Cytokeratin confirmed 296-Eur US Biomax tissue
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2, ER, PR, P53 and Ki-67, 75 cases_150 cores, replacing BR1502 278-Eur US Biomax tissue
BR1503 Breast cancer tissue array, including TNM and pathology grade, 75 cases_150 cores, replaced by BR1503a; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases_150 cores, replacing BR1503; ihc Anti- 296-Eur US Biomax tissue
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 321-Eur US Biomax tissue
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 266-Eur US Biomax tissue
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases_150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin 296-Eur US Biomax tissue
BR1921 High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_192 cores 456-Eur US Biomax tissue
BR1921 High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax elisa
BR2001 Breast cancer high-density tissue array, 196 cases_200 cores, replaced by BR2086 456-Eur US Biomax elisa
BR2001 Breast cancer high-density tissue array, 196 cases_200 cores, replaced by BR2086; ihc Anti-Proliferating Cell Nuclear Antigen (PCNA) confirmed 487-Eur US Biomax elisa
BR208 High-density, multiple breast cancer (1-3 grade) and normal breast tissue array, 70 cases_208 cores 456-Eur US Biomax tissue
BR208 High-density, multiple breast cancer (1-3 grade) and normal breast tissue array, 70 cases_208 cores, replaced by BR208b; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores 456-Eur US Biomax tissue
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR2083 High-density breast cancer tissue array with normal tissue, stage and grade info, 104 cases_208 cores 456-Eur US Biomax tissue
BR2083 High-density breast cancer tissue array with normal tissue, stage and grade info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR2085a High-density (188 cases_208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c. 456-Eur US Biomax tissue
BR2085a High-density (188 cases_208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR2085b High-density (188 cases_208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast 456-Eur US Biomax tissue
BR2085b High-density (188 cases_208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a 456-Eur US Biomax tissue
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001 456-Eur US Biomax tissue
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
BR208b TMA block of high-density (70 cases_208 cores), multiple breast cancer (I-3 grade) and normal breast tissue 40981-Eur US Biomax tissue
BR208b TMA block of high-density (70 cases_208 cores), multiple breast cancer (I-3 grade) and normal breast tissue, replacing BR208; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores 456-Eur US Biomax tissue
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
BR241 Breast cancer test tissue array with self-matched or unmatched normal adjacent tissues, 6 cases_24 cores. 88-Eur US Biomax assays
BR241 Breast cancer test tissue array with self-matched or unmatched normal adjacent tissues, 6 cases_24 cores.; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
BR242 Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases_24 cores, replaced by BR244 88-Eur US Biomax assays
BR242 Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases_24 cores, replaced by BR244; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
BR243 Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replaced by BR243a 88-Eur US Biomax tissue
BR243 Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replacing BR241; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243 99-Eur US Biomax tissue
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243 88-Eur US Biomax tissue
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replaced by BR243f; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by BR243d; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243c; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245 88-Eur US Biomax tissue
BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246 88-Eur US Biomax tissue
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a 88-Eur US Biomax tissue
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246 99-Eur US Biomax tissue
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246 88-Eur US Biomax tissue
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide 189-Eur US Biomax tissue
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results 160-Eur US Biomax tissue
BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results; ihc Anti-Cytokeratin (CK) confirmed 162-Eur US Biomax tissue
BR480 Breast disease spectrum tissue array - progression array, 48 cases_48 cores 314-Eur US Biomax tissue
BR480 Breast disease spectrum tissue array - progression array, 48 cases_48 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR481 Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores 160-Eur US Biomax rat
BR481 Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores; ihc Anti-actin confirmed Certified pathologist code Certified pathologist code 185-Eur US Biomax rat
BR482 Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases_48 cores, with stage and grade info 160-Eur US Biomax tissue
BR482 Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases_48 cores, with stage and grade info; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
BR483 Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases_48 cores 160-Eur US Biomax tissue
BR483 Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores 231-Eur US Biomax tissue
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores 397-Eur US Biomax elisa
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores; ihc Anti-Actin confirmed 382-Eur US Biomax elisa
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores 225-Eur US Biomax tissue
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores 189-Eur US Biomax tissue
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores 231-Eur US Biomax tissue
BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores; ihc Anti-Smooth Muscle Actin (SMA) confirmed 267-Eur US Biomax tissue
BR602 Breast tumor and normal tissue array, with TNM data, 25 cases_60 cores ----Eur US Biomax tissue
BR6161 High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases_616 cores 753-Eur US Biomax tissue
BR6161 High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases_616 cores; ihc Anti-Actin confirmed 811-Eur US Biomax tissue
BR641 Breast cancer tissue array, 64 cases_66 cores, with TNM data ----Eur US Biomax tissue
BR701 Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her-2 (C-erbB-2, neu<_em>) IHC results, replaced by BR962 231-Eur US Biomax elisa
BR701 Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her-2 (C-erbB-2, neu<_em>) IHC results, replaced by BR962; ihc Anti-Actin confirmed 296-Eur US Biomax elisa
BR721 Breast cancer tissue array with self-matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs 231-Eur US Biomax tissue
BR721 Breast cancer tissue array with self-matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BR722 Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages 231-Eur US Biomax recombinant
BR722 Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax recombinant
BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores 314-Eur US Biomax tissue
BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR724 Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores 231-Eur US Biomax tissue
BR724 Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR725 Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores 231-Eur US Biomax tissue
BR725 Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores 231-Eur US Biomax tissue
BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011 231-Eur US Biomax tissue
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015 231-Eur US Biomax tissue
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804 231-Eur US Biomax tissue
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804; ihc Anti-Cytokeratin (High MW) confirmed 267-Eur US Biomax tissue
BR8010 Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores 231-Eur US Biomax tissue
BR8010 Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores 314-Eur US Biomax tissue
BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014 231-Eur US Biomax tissue
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores 231-Eur US Biomax tissue
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012 231-Eur US Biomax tissue
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014 231-Eur US Biomax tissue
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
BR8016 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores 266-Eur US Biomax tissue
BR8016 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR8017 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores 266-Eur US Biomax tissue
BR8017 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014 266-Eur US Biomax tissue
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b 231-Eur US Biomax tissue
BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b; ihc Anti-Cytokeratin (High MW) con 267-Eur US Biomax tissue
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802 266-Eur US Biomax tissue
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR803 Breast carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores, replacing BC08016 189-Eur US Biomax tissue
BR803 Breast carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores, replaced by BR803a; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BR803; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases_80 cores 231-Eur US Biomax tissue
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804a; ihc Anti-Cytokeratin (Low-MW) confirmed 267-Eur US Biomax tissue
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR804; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR805 Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores 266-Eur US Biomax tissue
BR805 Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
BR806 Breast hyperplasia tissue array, 80 cases_80 cores 231-Eur US Biomax tissue
BR806 Breast hyperplasia tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BR807 Medullary carcinoma of breast tissue array, 80 cases_80 cores 231-Eur US Biomax tissue
BR807 Medullary carcinoma of breast tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases_80 cores, replaced by BR8018 231-Eur US Biomax tissue
BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases_80 cores, replaced by BR8018; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores 266-Eur US Biomax tissue
BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data 231-Eur US Biomax tissue
BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR812 Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data 231-Eur US Biomax tissue
BR812 Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, to be replaced by BR95 456-Eur US Biomax tissue
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR952; ihc 429-Eur US Biomax tissue
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores 456-Eur US Biomax tissue
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores; ihc Anti-Actin confir 429-Eur US Biomax tissue
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR952 456-Eur US Biomax tissue
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR954; ihc 429-Eur US Biomax tissue
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR953; ihc 429-Eur US Biomax tissue
BR961 Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases_96 cores, replaced by BR962 ----Eur US Biomax elisa
BR962 Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases_96 cores, replacing BR961, BR701 231-Eur US Biomax elisa
BR962 Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases_96 cores, replaced by BR963; ihc Anti-Vimentin_Cytokeratin confirmed 296-Eur US Biomax elisa
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her-2, Ki67, CK14 and p53), 48 cases_96 cores, replacing BR962 314-Eur US Biomax elisa
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her-2, Ki67, CK14 and p53), 48 cases_96 cores, replaced by BR963a; ihc Anti-Actin conf 296-Eur US Biomax elisa
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores, replacing BR963; ihc Anti-Actin confirmed 296-Eur US Biomax elisa
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 228-Eur US Biomax elisa
BRC1021 Breast cancer tissue array, 102 cases_102 cores 225-Eur US Biomax tissue
BRC1021 Breast cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
BRC1501 Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases_150 cores 225-Eur US Biomax tissue
BRC1501 Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
BRC1502 Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases_150 cores 225-Eur US Biomax tissue
BRC1502 Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores 225-Eur US Biomax tissue
BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
BRC2281 High density breast cancer tissue array, 228 cases_228 cores ----Eur US Biomax tissue
BRC2281 High density breast cancer tissue array, 228 cases_228 cores; ihc H&E, IHC anti-Cytokeratin 434-Eur US Biomax tissue
BRC481 Breast cancer and normal tissue array, 16 cases_48 cores 189-Eur US Biomax tissue
BRC481 Breast cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
BRC491 Human breast invasive ductal carcinoma (IDC) tissue array, non-overlapping with BRC711, 49 cases_49 cores 142-Eur US Biomax tissue
BRC491 Human breast invasive ductal carcinoma (IDC) tissue array, non-overlapping with BRC711, 49 cases_49 cores; ihc H&E, IHC anti- Cytokeratin 178-Eur US Biomax tissue
BRC51 Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed 4878-Eur US Biomax tissue
BRC711 Human breast invasive ductal cancer tissue array, non-overlapping with BRC491, 71 cases_72 cores 142-Eur US Biomax tissue
BRC711 Human breast invasive ductal cancer tissue array, non-overlapping with BRC491, 71 cases_72 cores; ihc H&E, IHC anti-Cytokeratin 178-Eur US Biomax tissue
BRC961 Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR_ER_PR_Her-2(neu) IHC results, 48 cases_96 cores 225-Eur US Biomax elisa
BRC961 Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR_ER_PR_Her-2(neu) IHC results, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores 225-Eur US Biomax elisa
BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
BRD181 Breast disease tissue array, 18 cases_18 cores 118-Eur US Biomax tissue
BRD181 Breast disease tissue array, 18 cases_18 cores; ihc H&E, IHC anti-Cytokeratin 123-Eur US Biomax tissue
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed 742-Eur US Biomax tissue
BRF401i Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed 742-Eur US Biomax tissue
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores 167-Eur US Biomax tissue
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores; ihc Anti-Actin confirmed 742-Eur US Biomax tissue
BRM481 Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases_48 cores 189-Eur US Biomax tissue
BRM481 Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores 314-Eur US Biomax elisa
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores; ihc H&E, IHC anti-Cytokeratin 281-Eur US Biomax elisa
BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases_80 cores, replacing BN08013 231-Eur US Biomax tissue
BRN801 Breast normal adjacent tissue (NAT) and cancer tissue array, 80 cases_80 cores, replaced by BRN801a; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
BS01011 Stomach cancer tissue array, 72 cases_72 cores 231-Eur US Biomax tissue
BS01011 Stomach cancer tissue array, 72 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BS01012 Stomach adenocarcinoma tissue array, 72 cases _72 cores 160-Eur US Biomax tissue
BS01012 Stomach adenocarcinoma tissue array, 72 cases _72 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS01032 Stomach adenocarcinoma (grade II) tissue array, 63 cases _63 cores, replaced by ST808 160-Eur US Biomax tissue
BS01032 Stomach adenocarcinoma (grade II) tissue array, 63 cases _63 cores, replaced by ST808; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BS01041 Stomach adenocarcinoma (grade III) tissue array, 22 cases _63 cores 160-Eur US Biomax tissue
BS01041 Stomach adenocarcinoma (grade III) tissue array, 22 cases _63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS01042 Stomach adenocarcinoma (grade III) tissue array, 22 cases _63 cores, replaced by ST723 160-Eur US Biomax tissue
BS01042 Stomach adenocarcinoma (grade III) tissue array, 22 cases _63 cores, replaced by ST723; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS02021 Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases_63 cores 160-Eur US Biomax tissue
BS02021 Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases_63 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS02031 Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases_63 cores, replaced by ES723 160-Eur US Biomax tissue
BS02031 Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases_63 cores, replaced by ES723; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS02041 Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases_63 cores 160-Eur US Biomax tissue
BS02041 Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases_63 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS02051 Esophagus adenocarcinoma tissue array, 33 cases_63 cores 160-Eur US Biomax tissue
BS02051 Esophagus adenocarcinoma tissue array, 33 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS03011 Hepatocellular carcinoma tissue array, 21 cases_63 cores, replaced by LV804 160-Eur US Biomax tissue
BS03011 Hepatocellular carcinoma tissue array, 21 cases_63 cores, replaced by LV804; ihc Anti-PCNA confirmed 185-Eur US Biomax tissue
BS03013 Hepatocellular carcinoma tissue array, 22 cases_63 cores 160-Eur US Biomax tissue
BS03013 Hepatocellular carcinoma tissue array, 22 cases_63 cores; ihc Anti-AFP confirmed 185-Eur US Biomax tissue
BS03014 Hepatocellular carcinoma tissue array, 63 cases_63 cores, replaced by LV809 160-Eur US Biomax tissue
BS03014 Hepatocellular carcinoma tissue array, 63 cases_63 cores, replaced by LV809; ihc Anti-AFP confirmed 185-Eur US Biomax tissue
BS04011 Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, replaced by LC808 160-Eur US Biomax tissue
BS04011 Lung cancer tissue array, including pathology grade, 64 cases_64 core, replaced by LC808; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS04031 Lung squamous cell carcinoma tissue array, 63 cases_64 cores, replaced by LC724 160-Eur US Biomax tissue
BS04031 Lung squamous cell carcinoma tissue array, 63 cases_64 cores, replaced by LC724; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS04041 Lung squamous cell carcinoma (grade II) tissue array, 21 cases_63 cores 160-Eur US Biomax tissue
BS04041 Lung squamous cell carcinoma (grade II) tissue array, 21 cases_63 cores; ihc Anti-H-CK confirmed 185-Eur US Biomax tissue
BS04071 Lung squamous cell carcinoma (grade III) tissue array, 21 cases_63 cores, replaced by LC723 160-Eur US Biomax tissue
BS04071 Lung squamous cell carcinoma (grade III) tissue array, 21 cases_63 cores, replaced by LC723; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS04081 Lung adenocarcinoma (grade II) tissue array, 21 cases_63 cores 160-Eur US Biomax tissue
BS04081 Lung adenocarcinoma (grade II) tissue array, 21 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 162-Eur US Biomax tissue
BS04102 Large cell carcinoma of lung tissue array, 21 cases_63 cores 231-Eur US Biomax tissue
BS04102 Large cell carcinoma of lung tissue array, 21 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
BS04111 Lung small cell carcinoma tissue array, 33 cases_63 cores 160-Eur US Biomax tissue
BS04111 Lung small cell carcinoma tissue array, 33 cases_63 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
BS05011 Colon adenocarcinoma tissue array, 23 cases_63 cores. 160-Eur US Biomax tissue
BS05011 Colon adenocarcinoma tissue array, 23 cases_63 cores.; ihc Anti-P53 confirmed 185-Eur US Biomax tissue
BS05021 Colon adenocarcinoma (grade I) tissue array, 23 cases_63 cores, replaced by CO723 160-Eur US Biomax tissue
BS05021 Colon adenocarcinoma (grade I) tissue array, 23 cases_63 cores, replaced by CO723; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS05031 Colon adenocarcinoma (grade II) tissue array, 21 cases_63 cores, replaced by CO724 160-Eur US Biomax tissue
BS05031 Colon adenocarcinoma (grade II) tissue array, 21 cases_63 cores, replaced by CO724; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS05041 Colon adenocarcinoma (grade III) tissue array, 23 cases_63 cores, replaced by CO725 189-Eur US Biomax tissue
BS05041 Colon adenocarcinoma (grade III) tissue array, 23 cases_63 cores, replaced by CO725; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax tissue
BS06011 Rectum adenocarcinoma tissue array, 22 cases_63 cores 160-Eur US Biomax recombinant
BS06011 Rectum adenocarcinoma tissue array, 22 cases_63 cores; ihc Anti-CEA confirmed 185-Eur US Biomax recombinant
BS06021 Rectum adenocarcinoma (grade I) tissue array, 21 cases_63 cores 160-Eur US Biomax recombinant
BS06021 Rectum adenocarcinoma (grade I) tissue array, 21 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax recombinant
BS06031 Rectum adenocarcinoma (grade II) tissue array, 21 cases_63 cores, replaced by RE723 160-Eur US Biomax recombinant
BS06031 Rectum adenocarcinoma (grade II) tissue array, 21 cases_63 cores, replaced by RE723; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax recombinant
BS06041 Rectum adenocarcinoma (grade III) tissue array, 21 cases_63 cores, replaced by RE724 160-Eur US Biomax recombinant
BS06041 Rectum adenocarcinoma (grade III) tissue array, 21 cases_63 cores, replaced by RE724; ihc Anti-Cytokeratin (Low-MW) confirmed 185-Eur US Biomax recombinant
BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727 160-Eur US Biomax tissue
BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727 ; ihc Anti-ER confirmed 185-Eur US Biomax tissue
BS09011 Uteral leiomyoma (hysteromyoma) tissue array, 30 cases_60 cores 231-Eur US Biomax tissue
BS09011 Uteral leiomyoma (hysteromyoma) tissue array, 30 cases_60 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BS17011 Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811 231-Eur US Biomax tissue
BS17011 Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811; ihc Anti-GFAP confirmed 267-Eur US Biomax tissue
BS17015 Brain glioma tissue array, 63 cases_63 cores, replaced by GL803 231-Eur US Biomax tissue
BS17015 Brain glioma tissue array, 63 cases_63 cores, replaced by GL803; ihc Anti-GFAP confirmed 267-Eur US Biomax tissue
BS17016 Brain glioma tissue array, 33 cases_63 cores 231-Eur US Biomax tissue
BS17016 Brain glioma tissue array, 33 cases_63 cores, replaced by BS17016a; ihc Anti-GFAP confirmed 267-Eur US Biomax tissue
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases_80 cores, replacing BS17016; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
BS17017 Brain gliocytoma tissue array, 63 cases_63 cores 231-Eur US Biomax tissue
BS17017 Brain gliocytoma tissue array, 63 cases_63 cores; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed 267-Eur US Biomax tissue
BS17018 Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805 231-Eur US Biomax tissue
BS17018 Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed 267-Eur US Biomax tissue
BS20011 Lymphoma tissue array, 30 cases_30 cores, replaced by NHL481 189-Eur US Biomax tissue
BS20011 Lymphoma tissue array, 30 cases_30 cores, replaced by NHL481; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
BS26011 Osteosarcoma tissue array, 32 cases_63 cores, replaced by OS804 231-Eur US Biomax tissue
BS26011 Osteosarcoma tissue array, 32 cases_63 cores, replaced by OS804; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803 266-Eur US Biomax tissue
BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803; ihc Anti-PCNA confirmed 267-Eur US Biomax tissue
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores 225-Eur US Biomax tissue
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
CKIT061 Ckit molecule IHC control array, 3 cases_6 cores 77-Eur US Biomax assays
CKIT061 Ckit molecule IHC control array, 3 cases_6 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 85-Eur US Biomax assays
CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases_60 cores 266-Eur US Biomax tissue
CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases_60 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CM241 Common 4 types of cancer tissue array, 12 cases_24 cores 88-Eur US Biomax tissue
CM241 Common 4 types of cancer tissue array, 12 cases_24 cores; ihc Anti-Vimentin (Vim) confirmed 105-Eur US Biomax tissue
CM481 Common 4 types of cancer tissue array, 48 cases_54 cores, with stage and grade data 231-Eur US Biomax tissue
CM481 Common 4 types of cancer tissue array, 48 cases_54 cores, with stage and grade data; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
CMA241 Human tumor cell array, 12 cell lines_24 cores 278-Eur US Biomax human
CMA241 Human tumor cell array, 12 cell lines_24 cores, replaced by CMA241a; ihc Anti-Actin confirmed 267-Eur US Biomax human
CMA241a Human tumor cell array, 12 cell lines_24 cores, replacing CMA241; ihc Anti-Actin confirmed 267-Eur US Biomax human
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores 516-Eur US Biomax tissue
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores 314-Eur US Biomax tissue
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO1002 Colon and rectum carcinoma and normal tissue array, 73 cases_100 cores, replaced by CO1002b 278-Eur US Biomax recombinant
CO1002 Colon and rectum carcinoma and normal tissue array, 73 cases_100 cores, replaced by CO1002b; ihc Anti-Actin confirmed 267-Eur US Biomax recombinant
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases_100 cores, replacing CO1002 321-Eur US Biomax recombinant
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases_100 cores, replacing CO1002 266-Eur US Biomax recombinant
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases_100 cores, replacing CO1002; ihc Anti-Actin confirmed 258-Eur US Biomax recombinant
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases_100 cores 231-Eur US Biomax
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores 231-Eur US Biomax tissue
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases_102 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO1501 Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 321-Eur US Biomax tissue
CO1501 Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 266-Eur US Biomax tissue
CO1501 Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CO1503 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CO1921 High-density colon cancer tissue array with normal tissues, 192 cases_192 cores 456-Eur US Biomax tissue
CO1921 High-density colon cancer tissue array with normal tissues, 192 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax elisa
CO2001 Colon cancer high-density tissue array, including TNM and pathology grade, 196 cases_200 core 397-Eur US Biomax elisa
CO2001 Colon cancer high-density tissue array, including TNM and pathology grade, 196 cases_200 core; ihc Anti-Cytokeratin (Low-MW) confirmed 429-Eur US Biomax elisa
CO208 High-density, multiple colon cancer (1-4 grade) and normal colon tissue array, 70 cases_208 cores 456-Eur US Biomax tissue
CO208 High-density, multiple colon cancer (1-4 grade) and normal colon tissue array, 70 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases_208 cores 456-Eur US Biomax tissue
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CO2083 High-density colon cancer tissue array with normal tissue, stage and grade info, 104 cases_208 cores 456-Eur US Biomax tissue
CO2083 High-density colon cancer tissue array with normal tissue, stage and grade info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CO2085a High-density (208 cases_208 cores), multiple type colon adenocarcinoma (I-4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue 456-Eur US Biomax tissue
CO2085a High-density (208 cases_208 cores), multiple type colon adenocarcinoma (I-4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
CO2085b TMA BLOCK of high-density (208 cases_208 cores), multiple type colon adenocarcinoma (I-4 grade) with normal colon from autopsy and cancer adjacent tissue 40981-Eur US Biomax tissue
CO2085b TMA BLOCK of high-density (208 cases_208 cores), multiple type colon adenocarcinoma (I-4 grade) with normal colon from autopsy and cancer adjacent tissue; ihc Anti-Cytokeratin (CK) confirmed 33112-Eur US Biomax tissue
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CO208b TMA Block of high-density (70 cases_208 cores), multiple colon cancer (1-4 grade) and normal colon tissue array block 40981-Eur US Biomax tissue
CO208b TMA Block of high-density (70 cases_208 cores), multiple colon cancer (1-4 grade) and normal colon tissue array block; ihc Anti-Cytokeratin (CK) confirmed 33112-Eur US Biomax tissue
CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases_216 cores 456-Eur US Biomax tissue
CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases_216 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CO241 Colon cancer test tissue array with self-matching normal adjacent tissue, 6 cases_24 cores 88-Eur US Biomax assays
CO241 Colon cancer test tissue array with self-matching normal adjacent tissue, 6 cases_24 cores, replaced by CO241a; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing CO241; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
CO242 Multiple colon cancer test tissue array with self-matching normal adjacent tissue, 10 cases_24 cores. 88-Eur US Biomax assays
CO242 Multiple colon cancer test tissue array with self-matching normal adjacent tissue, 10 cases_24 cores, replaced by CO242a; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing CO242; ihc Anti-Actin confirmed 81-Eur US Biomax tissue
CO243 Colon cancer tissue array with normal tissue controls, 9 cases_24 cores 88-Eur US Biomax tissue
CO243 Colon cancer tissue array with normal tissue controls, 9 cases_24 cores, replaced by CO243a; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax tissue
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing CO243; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores 189-Eur US Biomax tissue
CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO481 Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases_48 cores 160-Eur US Biomax tissue
CO481 Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases_48 cores; ihc Anti-actin confirmed Certified pathologist code Certified pathologist code 210-Eur US Biomax tissue
CO482 Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases_48 cores 160-Eur US Biomax tissue
CO482 Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 210-Eur US Biomax tissue
CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with stage and grade information 160-Eur US Biomax tissue
CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with stage and grade information; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CO484 Colon cancer tissue array with normal tissues with TNM and grade, 48 cases_48 cores 189-Eur US Biomax tissue
CO484 Colon cancer tissue array with normal tissues with TNM and grade, 48 cases_48 cores, replaced by CO484a; ihc Anti-Cytokeratin (CK) confirmed 210-Eur US Biomax tissue
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases_48 cores, replacing CO484; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_48 cores 231-Eur US Biomax tissue
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases_96 cores 397-Eur US Biomax elisa
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases_96 cores; ihc Anti-Cytokeratin (CK) confirmed 382-Eur US Biomax elisa
CO487 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases_48 cores 225-Eur US Biomax tissue
CO487 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases_48 cores 189-Eur US Biomax tissue
CO487 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
CO601 Colon cancer tissue array, with matched normal tissues, 29 cases_60 cores, with TNM data ----Eur US Biomax tissue
CO6161 High-density colon cancer array, with stage, grade and normal colon tissue, 322 cases_616 cores 753-Eur US Biomax tissue
CO6161 High-density colon cancer array, with stage, grade and normal colon tissue, 322 cases_616 cores; ihc Anti-Actin confirmed 811-Eur US Biomax tissue
CO641 Colon cancer tissue array, 64 cases_66 cores, with TNM data ----Eur US Biomax tissue
CO701 Colon cancer tissue array, with grade 1-4 and normal colon tissue, 70 cases_70 cores, with stage and grade information 231-Eur US Biomax tissue
CO701 Colon cancer tissue array, with grade 1-4 and normal colon tissue, 70 cases_70 cores, with stage and grade information; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases_69 cores, repalcing BC05115 266-Eur US Biomax tissue
CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases_69 cores, repalcing BC05115; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CO721 Colon cancer tissue array with stage and grade info, 24 cases_72 cores 231-Eur US Biomax tissue
CO721 Colon cancer tissue array with stage and grade info, 24 cases_72 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases_72 cores, replacing BC05021 231-Eur US Biomax tissue
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases_72 cores, replacing BC05021; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO723 Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05021 231-Eur US Biomax tissue
CO723 Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05021; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05031 278-Eur US Biomax tissue
CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05031; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05041 231-Eur US Biomax tissue
CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases_72 cores, replacing BS05041; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO726 Metastatic colon carcinoma tissue array, 24 cases_72 cores, replacing BC050112 266-Eur US Biomax tissue
CO726 Metastatic colon carcinoma tissue array, 24 cases_72 cores, replacing BC050112; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO801 Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases_80 cores, no overlaps with CO802 231-Eur US Biomax tissue
CO801 Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases_80 cores, no overlaps with CO802; ihc Anti-Cytokeratin (High MW) confirmed 267-Eur US Biomax tissue
CO802 Colon carcinoma (multi-tissue combined panel) tissue array, 80 cases_80 cores, no overlaps with CO801 189-Eur US Biomax tissue
CO802 Colon carcinoma (multi-tissue combined panel) tissue array, 80 cases_80 cores, no overlaps with CO801, replaced by CO802b; ihc Anti-Cytokeratin (CK) confirmed 258-Eur US Biomax tissue
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases_80 cores, replacing CO802; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CO802b Colon cancer tissue array with adjacent normal colon tissue, including pathology grade and clinical stage, 80 cases_80 cores, replacing CO802; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores 231-Eur US Biomax tissue
CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases_80 cores 231-Eur US Biomax tissue
CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases_80 cores, replaced by CO804a; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replcing CO804; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO805 Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases_80 cores 231-Eur US Biomax tissue
CO805 Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO806 Colon normal adjacent tissue array, replacing BN05012, 80 cases_80 cores 231-Eur US Biomax tissue
CO806 Colon normal adjacent tissue array, replacing BN05012, 80 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores 266-Eur US Biomax tissue
CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases_80 cores 266-Eur US Biomax tissue
CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO809 Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases_80 cores 263-Eur US Biomax recombinant
CO809 Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases_80 cores; ihc Anti-Actin confirmed 263-Eur US Biomax recombinant
CO811 Colon cancer tissue array with normal tissues from autopsy, with TNM data, 80 cases_80 cores 231-Eur US Biomax tissue
CO811 Colon cancer tissue array with normal tissues from autopsy, with TNM data, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CO812 Colon carcinoma and normal tissue array, 80 cases_80 cores 231-Eur US Biomax tissue
CO812 Colon carcinoma and normal tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases_95 cores 456-Eur US Biomax tissue
CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases_95 cores, to be replaced by CO952; ihc Anti-Cytokeratin (C 429-Eur US Biomax tissue
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases_95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi 429-Eur US Biomax tissue
CO961 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
CO991 Colorectal (colon and rectum) cancer with matched lymph node metastasis tissue array, 44 cases_99 cores. 266-Eur US Biomax recombinant
CO991 Colorectal (colon and rectum) cancer with matched lymph node metastasis tissue array, 44 cases_99 cores, replaced by CO992.; ihc Anti-Cytokeratin (High MW) confirmed 258-Eur US Biomax recombinant
CO992 Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases_99 cores 266-Eur US Biomax recombinant
CO992 Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases_99 cores, replacing CO991; ihc Anti-Cytokeratin (CK) confirmed 258-Eur US Biomax recombinant
COC1021 Colon cancer tissue array, 102 cases_102 cores 225-Eur US Biomax tissue
COC1021 Colon cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax tissue
COC1501 Colon cancer mid-density tissue array, non-overlapping with either COC1502 or COC1503, 75 cases_150 cores ----Eur US Biomax tissue
COC1501 Colon cancer mid-density tissue array, non-overlapping with either COC1502 or COC1503, 75 cases_150 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax tissue
COC1502 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1503 75 cases_150 cores ----Eur US Biomax tissue
COC1502 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1503 75 cases_150 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax tissue
COC1503 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1502, 75 cases_150 cores 225-Eur US Biomax tissue
COC1503 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1502, 75 cases_150 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax tissue
COC2281 High density colon cancer tissue array, 228 cases_ 228 cores ----Eur US Biomax tissue
COC2281 High density colon cancer tissue array, 228 cases_ 228 cores; ihc H&E, IHC anti- Cytokeratin 434-Eur US Biomax tissue
COC481 Colon cancer and normal tissue array, non-overlapping with COC482???16 cases_48 cores 166-Eur US Biomax tissue
COC481 Colon cancer and normal tissue array, non-overlapping with COC482???16 cases_48 cores; ihc H&E, IHC anti- Cytokeratin 205-Eur US Biomax tissue
COC482 Colon cancer and normal tissue array, non-overlapping with COC481???16 cases_48 cores 166-Eur US Biomax tissue
COC482 Colon cancer and normal tissue array, non-overlapping with COC481???16 cases_48 cores; ihc H&E, IHC anti- Cytokeratin 205-Eur US Biomax tissue
COC961 Colon cancer and normal tissue array, non-overlapping with COC962???48 cases_96 cores 189-Eur US Biomax elisa
COC961 Colon cancer and normal tissue array, non-overlapping with COC962???48 cases_96 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax elisa
COC962 Colon cancer and normal tissue array, non-overlapping with COC961, 48 cases_96 cores 189-Eur US Biomax elisa
COC962 Colon cancer and normal tissue array, non-overlapping with COC961, 48 cases_96 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax elisa
CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases_100 cores 231-Eur US Biomax tissue
CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases_100 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases_100 cores 231-Eur US Biomax
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores 231-Eur US Biomax tissue
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
CR1921 Middle-advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
CR1921 Middle-advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 429-Eur US Biomax elisa
CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage 456-Eur US Biomax tissue
CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CR2081 High-density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases_208 cores 456-Eur US Biomax tissue
CR2081 High-density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2082 High-density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases_208 cores 456-Eur US Biomax tissue
CR2082 High-density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
CR241 Cervix cancer test tissue array with self-matching or unmatched normal adjacent tissue, 11 cases_24 cores 88-Eur US Biomax assays
CR241 Cervix cancer test tissue array with self-matching or unmatched normal adjacent tissue, 11 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
CR242 Multiple cervix cancer test tissue array with self-matching or unmatched normal adjacent tissues, 22 cases_24 cores 88-Eur US Biomax assays
CR242 Multiple cervix cancer test tissue array with self-matching or unmatched normal adjacent tissues, 22 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_slide 160-Eur US Biomax tissue
CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_slide; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing CR241 189-Eur US Biomax tissue
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing CR241; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed 105-Eur US Biomax tissue
CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data 160-Eur US Biomax tissue
CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CR482 Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases_48 cores, with grade and stage data 160-Eur US Biomax tissue
CR482 Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CR483 Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with TNM data 160-Eur US Biomax tissue
CR483 Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with TNM data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases_48 cores 225-Eur US Biomax tissue
CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases_48 cores 189-Eur US Biomax tissue
CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores 231-Eur US Biomax tissue
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR501 Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores 160-Eur US Biomax tissue
CR501 Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I-III), 59 cases_60 cores, replaced by CR602 231-Eur US Biomax tissue
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I-III), 59 cases_60 cores, replaced by CR602; ihc Anti-Cytokeratin (CK) 267-Eur US Biomax tissue
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases_60 cores, replacing CR601 231-Eur US Biomax tissue
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases_60 cores, replacing CR601; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CR6161 High-density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases_616 cores 872-Eur US Biomax tissue
CR6161 High-density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases_616 cores; ihc Anti-Actin confirmed 811-Eur US Biomax tissue
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores 266-Eur US Biomax tissue
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR721 Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases_72 cores 231-Eur US Biomax tissue
CR721 Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores 231-Eur US Biomax tissue
CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CR803 Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases_80 cores, replacing BS10011 231-Eur US Biomax tissue
CR803 Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases_80 cores, replacing BS10011; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
CR804 Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores 231-Eur US Biomax tissue
CR804 Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR805 Cervix cancer and normal tissue array, with stage and grade info, 80 cases_80 cores 231-Eur US Biomax tissue
CR805 Cervix cancer and normal tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR806 Mid-advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases_80 cores 266-Eur US Biomax tissue
CR806 Mid-advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CR811 Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data 231-Eur US Biomax tissue
CR811 Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CVD231 Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases_23 cores 166-Eur US Biomax tissue
CVD231 Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases_23 cores; ihc H&E, IHC anti-CD34 178-Eur US Biomax tissue
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores 189-Eur US Biomax tissue
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores; ihc H&E, IHC anti-CD34 205-Eur US Biomax tissue
CXC1021 Cervix cancer tissue array, 102 cases_102 cores 225-Eur US Biomax tissue
CXC1021 Cervix cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
CXC1501 Cervical cancer mid-density tissue array, 75 cases_150 cores 225-Eur US Biomax tissue
CXC1501 Cervical cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
CXC241 Cervical cancer tissue array, 12 cases_24 cores 189-Eur US Biomax tissue
CXC241 Cervical cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
CXC481 Cervix cancer and normal tissue array, 16 cases_48 cores 225-Eur US Biomax tissue
CXC481 Cervix cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
CXC961 Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases_96 cores 225-Eur US Biomax elisa
CXC961 Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
CXC962 Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases_96 cores 225-Eur US Biomax elisa
CXC962 Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases_99 cores 314-Eur US Biomax tissue
CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases_99 cores, replaced by CyFDA1; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs_99 cores, replacing CyFDA; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
DGS2081 Digestive system tissue array, including TNM, stage and grade, 104 cases_208 cores 456-Eur US Biomax tissue
DGS2081 Digestive system tissue array, including TNM, stage and grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
DID381 Digestive system disease tissue array, 38 cases_38 cores 166-Eur US Biomax tissue
DID381 Digestive system disease tissue array, 38 cases_38 cores; ihc H&E, IHC anti- Cytokeratin 178-Eur US Biomax tissue
DOG1061 GIST DOG1 molecule IHC control array, 3 cases_6 cores 77-Eur US Biomax dog
DOG1061 GIST DOG1 molecule IHC control array, 3 cases_6 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 85-Eur US Biomax dog
EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases_102 cores 314-Eur US Biomax tissue
EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases_102 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
EMC1021 Endometrial cancer tissue array, 102 caese_102 cores 225-Eur US Biomax tissue
EMC1021 Endometrial cancer tissue array, 102 caese_102 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
EMC1501 Endometrial cancer mid-density tissue array, non-overlapping with EMC1502, 75 cases_150 cores 225-Eur US Biomax tissue
EMC1501 Endometrial cancer mid-density tissue array, non-overlapping with EMC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
EMC1502 Endometrial cancer mid-density tissue array, non-overlapping with EMC1501, 75 caese_150 cores 225-Eur US Biomax tissue
EMC1502 Endometrial cancer mid-density tissue array, non-overlapping with EMC1501, 75 caese_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
EMC241 Endometrium cancer tissue array, 12 cases_24 cores 189-Eur US Biomax tissue
EMC241 Endometrium cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
EMC961 Endometrial cancer and normal tissue array, non-overlapping with EMC962, 48 cases_96 cores 225-Eur US Biomax elisa
EMC961 Endometrial cancer and normal tissue array, non-overlapping with EMC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
EMC962 Endometrial cancer and normal tissue array, non-overlapping with EMC961???48 cases_96 cores 225-Eur US Biomax elisa
EMC962 Endometrial cancer and normal tissue array, non-overlapping with EMC961???48 cases_96 cores; ihc H&E, IHC anti- Cytokeratin 238-Eur US Biomax elisa
EN801 Endocrine tumor tissue array, 40 cases_80 cores. 266-Eur US Biomax tissue
EN801 Endocrine tumor tissue array, 40 cases_80 cores, replaced by EN801a; ihc IHC confirmed 296-Eur US Biomax tissue
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases_80 cores, replacing EN801; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
ERC031 Estrogen receptor IHC control array, 3 cases_3 cores 77-Eur US Biomax recombinant
ERC031 Estrogen receptor (ER) IHC control array, 3 cases_3 cores; ihc H&E, IHC anti-ER 85-Eur US Biomax recombinant
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 266-Eur US Biomax tissue
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores 266-Eur US Biomax tissue
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases_120 cores, replaced by ES1202 278-Eur US Biomax tissue
ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases_120 cores, replaced by ES1202; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases_120 cores, replacing ES1201 278-Eur US Biomax tissue
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases_120 cores, replacing ES1201; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 321-Eur US Biomax tissue
ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 266-Eur US Biomax tissue
ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
ES1921 Middle-advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
ES1921 Middle-advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 296-Eur US Biomax elisa
ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases_200 cores 516-Eur US Biomax tissue
ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases_200 cores; ihc Anti-Cytokeratin 429-Eur US Biomax tissue
ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases_208 cores 456-Eur US Biomax tissue
ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases_208 cores 456-Eur US Biomax tissue
ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
ES2082 High-density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases_208 cores 456-Eur US Biomax tissue
ES2082 High-density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
ES241 Esophagus cancer test tissue array with self-matching normal adjacent tissue, 6 cases_24 cores 88-Eur US Biomax assays
ES241 Esophagus cancer test tissue array with self-matching normal adjacent tissue, 6 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
ES242 Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases_24 cores 88-Eur US Biomax assays
ES242 Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores 189-Eur US Biomax tissue
ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases_48 cores) with stage and grade info 160-Eur US Biomax tissue
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases_48 cores) with stage and grade info; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
ES482 Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with grade and stage data 160-Eur US Biomax tissue
ES482 Multiple esophagus cancer tissue array with unmatched normal tissues, 48 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed 162-Eur US Biomax tissue
ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases_48 cores 189-Eur US Biomax tissue
ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES721 Esophagus cancer and normal tissue array with TNM and grade info, 24 cases_72 cores 231-Eur US Biomax tissue
ES721 Esophagus cancer and normal tissue array with TNM and grade info, 24 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases_72 cores, replacing BC02023 231-Eur US Biomax tissue
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases_72 cores, replacing BC02023; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases_72 cores, replacing BS02031 231-Eur US Biomax tissue
ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases_72 cores, replacing BS02031; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases_78 cores, replacing BC02111 266-Eur US Biomax tissue
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases_78 cores, replacing BC02111; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES801 Esophagus cancer, with matched normal adjacent tissue array, 40 cases_80 cores, replaced by ES8010 231-Eur US Biomax tissue
ES801 Esophagus cancer, with matched normal adjacent tissue array, 40 cases_80 cores, replaced by ES8010; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases_80 cores, replacing ES801 231-Eur US Biomax tissue
ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases_80 cores, replacing ES801; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases_80 cores 231-Eur US Biomax tissue
ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
ES8012 Middle-advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores 278-Eur US Biomax tissue
ES8012 Middle-advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
ES802 Esophageal squamous cell carcinoma tissue array, grade I-III, 40 cases_80 cores, no overlaps with ES801 231-Eur US Biomax tissue
ES802 Esophageal squamous cell carcinoma tissue array, grade I-III, 40 cases_80 cores, no overlaps with ES801; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
ES803 Esophageal inflammation, hyperplasia and atypical hyperplasia tissue array, 80 cases_80 cores 231-Eur US Biomax tissue
ES803 Esophageal inflammation, hyperplasia and atypical hyperplasia tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
ES804 Esophageal cancer progression tissue array, 76 cases_80 cores 231-Eur US Biomax tissue
ES804 Esophageal cancer progression tissue array, 76 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
ES805 Esophagus cancer and normal tissue array, with grade and stage data, 40 cases_80 cores 231-Eur US Biomax tissue
ES805 Esophagus cancer and normal tissue array, with grade and stage data, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES806 Metastatic esophageal cancer tissue array, 40 cases_80 cores 231-Eur US Biomax tissue
ES806 Metastatic esophageal cancer tissue array, 40 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES807 Esophageal cancer and normal tissue array, with stage and grade info, 80 cases_80 cores 231-Eur US Biomax tissue
ES807 Esophageal cancer and normal tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES808 Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases_80 cores 231-Eur US Biomax tissue
ES808 Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases_80 cores 231-Eur US Biomax tissue
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES810 Esophagus cancer with matched lymph node metastasis tissue array, 40 cases_80 cores 231-Eur US Biomax tissue
ES810 Esophagus cancer with matched lymph node metastasis tissue array, 40 cases_80 cores; ihc Anti-Cytokeratin (Low-MW) confirmed 296-Eur US Biomax tissue
ES811 Esophageal cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, plus grade and stage information 231-Eur US Biomax tissue
ES811 Esophageal cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, plus grade and stage information; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases_96 cores 336-Eur US Biomax elisa
ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases_96 cores 278-Eur US Biomax elisa
ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
ESC1021 Esophagus cancer tissue array, 102 cases_102 cores 225-Eur US Biomax tissue
ESC1021 Esophagus cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 238-Eur US Biomax tissue
ESC1501 Esophageal cancer mid-density tissue array, non-overlapping with ESC1502???75 cases_150 cores 225-Eur US Biomax tissue
ESC1501 Esophageal cancer mid-density tissue array, non-overlapping with ESC1502???75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
ESC1502 Esophagus cancer mid-density tissue array, non-overlapping with ESC1501, 75 cases_150 cores ----Eur US Biomax tissue
ESC241 Esophagus cancer tissue array, 12 cases_24 cores 166-Eur US Biomax tissue
ESC241 Esophagus cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
ESC242 Esophagus cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
ESC481 Esophagus cancer and normal tissue array, 16 cases_48 cores 189-Eur US Biomax tissue
ESC481 Esophagus cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
ESC961 Esophageal cancer tissue array, non-overlapping with ESC962, 48 cases_96 cores 189-Eur US Biomax elisa
ESC961 Esophageal cancer tissue array, non-overlapping with ESC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
ESC962 Esophagus cancer tissue array, non-overlapping with ESC961, 48 cases_96 cores 189-Eur US Biomax elisa
ESC962 Esophagus cancer tissue array, non-overlapping with ESC961, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases_40 cores; ihc Anti-Actin confirmed 278-Eur US Biomax tissue
FBN404 Multiple organ normal frozen tissue array, 20 cases_40 cores 167-Eur US Biomax tissue
FBN404 Multiple organ normal frozen tissue array, 20 cases_40 cores; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FBN406 Multiple organ normal frozen tissue array, 20 cases_40 cores, replacing FBN404 167-Eur US Biomax tissue
FBN406 Multiple organ normal frozen tissue array, 20 cases_40 cores, replacing FBN404; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FBN406a Multiple organ normal frozen tissue array, 20 organs_40 cores; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FBN407 Multiple organ normal frozen tissue array, 20 cases_40 cores, replacing FBN404 281-Eur US Biomax tissue
FBN407 Multiple organ normal frozen tissue array, 20 cases_40 cores, replaced by FBN407a; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FBN407a Multiple organ normal frozen tissue array, 20 cases_40 cores, replaing FBN407; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases_40 cores, replaced by FCO401a 293-Eur US Biomax recombinant
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases_40 cores, replaced by FCO401a; ihc Anti-Actin confirmed 626-Eur US Biomax recombinant
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases_40 cores, replacing FCO401 781-Eur US Biomax recombinant
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases_40 cores, replacing FCO401 331-Eur US Biomax recombinant
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases_40 cores, replacing FCO401; ihc Anti-Actin confirmed 626-Eur US Biomax recombinant
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers_72 cores, replacing FDA802-2 or FDA803-2 266-Eur US Biomax tissue
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers_72 cores, replacing FDA802-2 or FDA803-2; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies. 278-Eur US Biomax assays
FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies.; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies. 278-Eur US Biomax assays
FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies.; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies. 278-Eur US Biomax assays
FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies.; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies 278-Eur US Biomax assays
FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA804-2 Multiple tumor and 6 types of normal organ tissue array (slide 2 of 2 slide set), replacing FDA803-2, recommended by FDA to test tissue specificity, 72 cases_72 cores, replaced by FDA807-2 278-Eur US Biomax recombinant
FDA804-2 Multiple tumor and 6 types of normal organ tissue array (slide 2 of 2 slide set), replacing FDA803-2, recommended by FDA to test tissue specificity, 72 cases_72 cores, replaced by FDA807-2; ihc Anti- 267-Eur US Biomax recombinant
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies 314-Eur US Biomax assays
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases_72 cores, replaced by FDA808-2 278-Eur US Biomax tissue
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases_72 cores, replaced by FDA808-2; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies 380-Eur US Biomax assays
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies 314-Eur US Biomax assays
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA807-1 Multiple organ normal tissue array, tissue 72 cores, replaced by FDA808-1; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replacing FDA806-2 336-Eur US Biomax tissue
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replacing FDA806-2 278-Eur US Biomax tissue
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replacing FDA806-2; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA808-1 Multiple organ normal tissue array, tissue 72 cores, replaced by FDA808a-1; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replacing FDA805-2 277-Eur US Biomax tissue
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replacing FDA805-2 231-Eur US Biomax tissue
FDA808-2 Multiple normal organ and tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases_72 cores, replaced by FDA808a-2; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases_144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA808a-1 Multiple organ normal tissue array, 72 cases_72 cores, replacing FDA808-1; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing FDA808-2; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih 1438-Eur US Biomax tissue
FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed 858-Eur US Biomax tissue
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed 858-Eur US Biomax tissue
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ 199-Eur US Biomax recombinant
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replaced 1206-Eur US Biomax recombinant
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases_45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed 858-Eur US Biomax tissue
FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep 1206-Eur US Biomax tissue
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing 1206-Eur US Biomax recombinant
FDA902b-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FDA902-2; ihc Anti-Actin confirmed 1206-Eur US Biomax tissue
FDA992 FDA normal organ tissue array of human tissue, 67cases_100 cores 278-Eur US Biomax tissue
FDA992 FDA normal organ tissue array of human tissue, 67cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA993 FDA normal human organ tissue array, 67cases_100 cores, replaced by FDA995 278-Eur US Biomax tissue
FDA993 FDA normal human organ tissue array, 67cases_100 cores, replaced by FDA995; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA994 FDA normal human organ tissue array, 99 cores_33 sites_75 cases, replacing FDA993, replaced by FDA995 314-Eur US Biomax tissue
FDA994 FDA normal human organ tissue array, 99 cores_33 sites_75 cases, replacing FDA993, replaced by FDA995; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA995 FDA normal human organ tissue array, 99 cores_33 sites_75 cases, replaced by FDA997 278-Eur US Biomax tissue
FDA995 FDA normal human organ tissue array, 99 cores_33 sites_75 cases, replaced by FDA997; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA997 FDA normal organ tissue array of human, 47 cases_99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 314-Eur US Biomax assays
FDA997 FDA normal organ tissue array of human, 47 cases_99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998; ihc Anti-Actin confirmed 296-Eur US Biomax assays
FDA998 FDA normal organ tissue array of human, 47 cases_99 cores, replaced by FDA999 314-Eur US Biomax tissue
FDA998 FDA normal organ tissue array of human, 47 cases_99 cores, replaced by FDA999; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA999 Multiple organ normal tissue array, 47 cases_99 cores, replacing FDA998 314-Eur US Biomax tissue
FDA999 Multiple organ normal tissue array, 47 cases_99 cores, replaced by FDA999a; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDA999a Multiple organ normal tissue array, 47 cases_99 cores, replacing FDA999; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
FDG281f Normal dog multiple organ frozen tissue array, 28 cases_28 cores 199-Eur US Biomax tissue
FDG281f Normal dog multiple organ frozen tissue array, 28 cases_28 cores; ihc Anti-Actin confirmed 278-Eur US Biomax tissue
FDG281m Normal male dog multiple organ frozen tissue array, 28 cases_28 cores 199-Eur US Biomax tissue
FDG281m Normal male dog multiple organ frozen tissue array, 24 organs_24 cores; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FFE301 Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs_30 cores, replaced by FFE302 199-Eur US Biomax tissue
FFE301 Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs_30 cores, replaced by FFE302; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FFE302 Multiple organ normal frozen tissue array, 15 cases_30 cores, replacing FFE301 199-Eur US Biomax tissue
FFE302 Multiple organ normal frozen tissue array, 15 cases_30 cores, replacing FFE301; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FFE302a Multiple organ normal frozen tissue array, 15 organs_30 cores; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases_28 cores, previously named FMC401 91-Eur US Biomax tissue
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases_28 cores, previously named FMC401; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FMC282 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 28 cases_28 cores,replaced by FMC282a; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases_28 cores, replacing FMC282; ihc Anti-Actin confirmed 394-Eur US Biomax tissue
FMC401 Multiple organ cancer frozen tissue array, 20 cases_40 cores; ihc Anti-Actin confirmed 510-Eur US Biomax tissue
FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases_40 cores 91-Eur US Biomax tissue
FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases_40 cores, replaced by FMC402a; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases_40 cores, replaced by FMC402b; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases_40 cores, replacing FMC402a; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases_40 cores 167-Eur US Biomax tissue
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases_40 cores, replaced by FMC405a; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases_40 cores, replacing FMC405; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases_40 cores 167-Eur US Biomax tissue
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases_40 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases_40 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases_40 cores 331-Eur US Biomax tissue
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases_40 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases_40 cores, replacing FMC407; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases_40 cores 167-Eur US Biomax tissue
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases_40 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC409 Multiple organ cancer frozen tissue array, 20 cases_40 cores???replacing FMC401 281-Eur US Biomax tissue
FMC409 Multiple organ cancer frozen tissue array, 20 cases_40 cores???replacing FMC401; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMC409a Frozen multiple organ cancer tissue array, 20 cases_40 cores, replacing FMC409; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases_72 cores 293-Eur US Biomax tissue
FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases_72 cores; ihc Anti-Actin confirmed 742-Eur US Biomax tissue
FMO901 FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs_45 cores 293-Eur US Biomax tissue
FMO901 FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs_45 cores; ihc Anti-Actin confirmed 858-Eur US Biomax tissue
FMO901-1 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 15 organs_45 cores, slide 1 of 2 tissue arrays; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs_45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FMS151 Brains of multiple species frozen tissue array, 14 cases_15 cores 293-Eur US Biomax tissue
FMS151 Brains of multiple species frozen tissue array, 14 cases_15 cores; ihc Anti-Actin confirmed 220-Eur US Biomax tissue
FMS152 Liver of multiple species frozen tissue array, 14 cases_15 cores 293-Eur US Biomax tissue
FMS152 Liver of multiple species frozen tissue array, 14 cases_15 cores; ihc Anti-Actin confirmed 220-Eur US Biomax tissue
FRA781 FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases_78 cores 331-Eur US Biomax tissue
FRA781 Standard normal rat multiple organ frozen tissue array, two slides, 26 cases_78 cores; ihc Anti-Actin confirmed 742-Eur US Biomax tissue
FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases_78 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases_78 cores; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases_45 cores 331-Eur US Biomax recombinant
FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases_45 cores; ihc Anti-Actin confirmed 858-Eur US Biomax recombinant
FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases_45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed 626-Eur US Biomax tissue
FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases_45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed 626-Eur US Biomax recombinant
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases_45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed 858-Eur US Biomax tissue
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c 626-Eur US Biomax tissue
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c 626-Eur US Biomax tissue
FRB281f Normal female rabbit multiple organ frozen tissue array, 28 cases_28 cores 293-Eur US Biomax polyclonal
FRB281f Normal female rabbit multiple organ frozen tissue array, 28 organs_28 cores; ihc Anti-Actin confirmed 278-Eur US Biomax polyclonal
FRB281m Normal male rabbit multiple organ frozen tissue array, 28 cases_28 cores 293-Eur US Biomax polyclonal
FRB281m Normal male rabbit multiple organ frozen tissue array, 25 organs_25 cores; ihc Anti-Actin confirmed 394-Eur US Biomax polyclonal
FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs_45 cores 331-Eur US Biomax polyclonal
FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs_45 cores; ihc Anti-Actin confirmed 626-Eur US Biomax polyclonal
FRS801 Female reproductive system tissue array, with stage and grade info, 80 cases_80 cores 314-Eur US Biomax tissue
FRS801 Female reproductive system tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases_208 cores 236-Eur US Biomax tissue
GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases_80 cores 123-Eur US Biomax tissue
GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 382-Eur US Biomax tissue
GI101 Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases_100 cores 266-Eur US Biomax assays
GI101 Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax assays
GI481 GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases_48 cores 160-Eur US Biomax recombinant
GI481 GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 162-Eur US Biomax recombinant
GI961 GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases_96 cores 231-Eur US Biomax elisa
GI961 GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases_96 cores; ihc Anti-Cytokeratin (CK) confirmed 228-Eur US Biomax elisa
GIP541 Visceral peritoneum tissue array, 27 cases_54 cores 173-Eur US Biomax tissue
GIP541 Visceral peritoneum tissue array, 27 cases_54 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
GIST481 Gastrointestinal stromal tumor tissue array, 24 cases_48 cores 225-Eur US Biomax assays
GIST481 Gastrointestinal stromal tumor tissue array, 24 cases_48 cores; ihc H&E, IHC anti- CD117, CD34, S100 238-Eur US Biomax assays
GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases_80 cores 231-Eur US Biomax assays
GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax assays
GIST802 Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases_80 cores, no overlapping with GIST8 296-Eur US Biomax recombinant
GL1001 Multiple brain cancer and normal adjacent tissue array, 100 cases_100 cores 266-Eur US Biomax tissue
GL1001 Multiple brain cancer and normal adjacent tissue array, 100 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
GL1002 Brain tumor and normal tissue array, 50 cases_100 cores 266-Eur US Biomax tissue
GL1002 Brain tumor and normal tissue array, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
GL1003 Brain tumor tissue array for antibody screening, 25 cases_100 cores 266-Eur US Biomax tissue
GL1003 Brain tumor tissue array for antibody screening, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
GL1921 Mid-advanced stage brain tumor tissue array, including pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
GL1921 Mid-advanced stage brain tumor tissue array, including pathology grade, 96 cases_192 cores; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax elisa
GL208 Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue 456-Eur US Biomax tissue
GL208 Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores 456-Eur US Biomax tissue
GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores, replaced by GL2083a; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
GL241 Multiple brain cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores 88-Eur US Biomax tissue
GL241 Multiple brain cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores, replaced by GL241a; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed 90-Eur US Biomax tissue
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases_24 cores, replacing GL241; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores 189-Eur US Biomax tissue
GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
GL481 Multiple brain cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores 160-Eur US Biomax tissue
GL481 Astrocytoma and glioblastoma tissue array with unmatched normal adjacent tissues, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
GL482 Brain tumor tissue array, with normal tissue, 48 cases_48 cores 231-Eur US Biomax tissue
GL482 Brain tumor tissue array, with normal tissue, 48 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores 266-Eur US Biomax tissue
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
GL722 Brain glioma (astrocytoma) tissue array, 24 cases_72 cores 266-Eur US Biomax tissue
GL722 Brain glioma (astrocytoma) tissue array, 24 cases_72 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores 231-Eur US Biomax tissue
GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores; ihc Anti-Glial Fibrillary acid protein antibody confirmed 267-Eur US Biomax tissue
GL802 Glioblastoma (grade IV) tissue array, 40 cases_80 cores, replaced by GL805 231-Eur US Biomax tissue
GL802 Glioblastoma (grade IV) tissue array, 40 cases_80 cores, replaced by GL805; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed 267-Eur US Biomax tissue
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replacing BS17015 266-Eur US Biomax tissue
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replaced by GL803a; ihc Anti-Glial Fibrillary Acid Prot 296-Eur US Biomax tissue
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases_80 cores, replacing GL803; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores 266-Eur US Biomax tissue
GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
GL805 Glioblastoma multiforme (GBM) tissue array, 40 cases_80 cores, replaced by GL806 266-Eur US Biomax tissue
GL805 Glioblastoma multiforme (GBM) tissue array, 40 cases_80 cores, replaced by GL806; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
GL806 Brain glioblastoma and normal tissue array, 40 cases_80 cores, replacing GL805 266-Eur US Biomax tissue
GL806 Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replaced by GL806a; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replacing GL806; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
GL807 Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores 266-Eur US Biomax tissue
GL807 Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores 266-Eur US Biomax tissue
GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011 266-Eur US Biomax tissue
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases_100 cores 266-Eur US Biomax tissue
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
HER2 Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases_10 cores; ihc Anti-Actin confirmed 114-Eur US Biomax assays
HL481 Hodgkin's lymphoma tumor tissue array, 48 cases_48 cores 231-Eur US Biomax tissue
HL481 Hodgkin's lymphoma tumor tissue array, 48 cases_48 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
HL801 Hodgkin's lymphoma tissue array, 45 cases_80 cores 266-Eur US Biomax tissue
HL801 Hodgkin's lymphoma tissue array, 45 cases_80 cores; ihc Anti-Leukocyte Common Antigen antibody confirmed 267-Eur US Biomax tissue
HN241 Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases_24 cores 88-Eur US Biomax assays
HN241 Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases_24 cores, replaced by HN241a; ihc Anti-Cytokeratin (CK) confirmed 90-Eur US Biomax assays
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN241; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
HN242 Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases_24 cores 88-Eur US Biomax assays
HN242 Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases_24 cores, replaced by HN242a; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN242; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
HN481 Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases_48 cores with stage and grade data 160-Eur US Biomax tissue
HN481 Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases_48 cores with stage and grade data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases_48 cores with stage and grade data, replaced by HN483 160-Eur US Biomax tissue
HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases_48 cores with stage and grade data, replaced by HN483; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases_48 cores, replacing HN482 160-Eur US Biomax tissue
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases_48 cores, replacing HN482; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases_80 cores 266-Eur US Biomax tissue
HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases_80 cores 266-Eur US Biomax tissue
HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases_80 cores 266-Eur US Biomax tissue
HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases_80 cores, replaced by HN803a; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing HN803; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases_81 cores, replacing BC34111 266-Eur US Biomax tissue
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases_81 cores, replacing BC34111; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
HND181 Head and neck disease tissue array, 18 cases_18 cores 166-Eur US Biomax tissue
HND181 Head and neck disease tissue array, 18 cases_18 cores; ihc H&E, IHC anti-Cytokeratin 178-Eur US Biomax tissue
HNT961 Head and neck disease tissue array, 48 cases_96 cores 225-Eur US Biomax elisa
HNT961 Head and neck disease tissue array, 48 cases_96 cores; ihc H&E, IHC anti-Vimentin_cytokeratin 238-Eur US Biomax elisa
HRC041 HER2 IHC control array, 4 cases_4 cores 77-Eur US Biomax
HRC041 HER2 IHC control array, 4 cases_4 cores; ihc H&E, IHC anti-HER2 85-Eur US Biomax
IC00011 Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases _80 cores, replaced by IC00011b 231-Eur US Biomax assays
IC00011 Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases _80 cores, replaced by IC00011b; ihc Anti-Cytokeratin (Low MW) confirmed 267-Eur US Biomax assays
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing IC00011 321-Eur US Biomax assays
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing IC00011 266-Eur US Biomax assays
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing IC00011; ihc Anti-Actin confirmed 258-Eur US Biomax assays
IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases_ 80 cores, replaced by LV805 231-Eur US Biomax tissue
IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases_ 80 cores, replaced by LV805; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 231-Eur US Biomax tissue
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores 231-Eur US Biomax tissue
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
KD1502 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
KD1921 Mid-advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
KD1921 Mid-advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 429-Eur US Biomax elisa
KD208 High density tissue array (70 cases_208 cores) of kidney cancer and normal tissue 456-Eur US Biomax tissue
KD208 High density tissue array (70 cases_208 cores) of kidney cancer and normal tissue; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD2082 High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases_208 cores 456-Eur US Biomax tissue
KD2082 High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2083 Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases_208 cores 456-Eur US Biomax tissue
KD2083 Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores 456-Eur US Biomax tissue
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases_24 cores 88-Eur US Biomax assays
KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
KD242 Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases_24 cores 88-Eur US Biomax assays
KD242 Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed 105-Eur US Biomax assays
KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores 189-Eur US Biomax tissue
KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed 90-Eur US Biomax tissue
KD481 Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases_48 cores 160-Eur US Biomax tissue
KD481 Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases_48 cores 160-Eur US Biomax tissue
KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
KD483 Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with stage and grade data 160-Eur US Biomax tissue
KD483 Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores, with stage and grade data; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases_48 cores 189-Eur US Biomax tissue
KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases_48 cores 189-Eur US Biomax tissue
KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases_48 cores 225-Eur US Biomax tissue
KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases_48 cores 189-Eur US Biomax tissue
KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
KD6161 High-density renal cancer array, with stage, grade and normal renal tissue, 322 cases_616 cores 753-Eur US Biomax tissue
KD6161 High-density renal cancer array, with stage, grade and normal renal tissue, 322 cases_616 cores; ihc Anti-Actin confirmed 811-Eur US Biomax tissue
KD801 Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases_80 cores 231-Eur US Biomax tissue
KD801 Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases_80 cores; ihc Anti-Cytokeratin (High MW) confirmed 228-Eur US Biomax tissue
KD802 Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases_80 cores 231-Eur US Biomax tissue
KD802 Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
KD803 Normal kidney tissue array, replacing BN07012, 80 cases_80 cores 231-Eur US Biomax tissue
KD803 Normal kidney tissue array, replacing BN07012, 80 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases_80 cores, with stage and grade information 231-Eur US Biomax tissue
KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases_80 cores, with stage and grade information; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores 231-Eur US Biomax tissue
KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases_80 cores 231-Eur US Biomax tissue
KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD808 Mid-advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores 231-Eur US Biomax tissue
KD808 Mid-advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
KD811 Renal carcinoma and normal tissue array, with TNM, 40 cases_80 cores 231-Eur US Biomax tissue
KD811 Kidney carcinoma and normal tissue array, with TNM, 40 cases_80 cores; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases_95 cores 456-Eur US Biomax tissue
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases_95 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
KD962 Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
KD991 Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases_99 cores 231-Eur US Biomax tissue
KD991 Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases_99 cores; ihc Anti-Cytokeratin (High MW) confirmed 267-Eur US Biomax tissue
KIC1501 Kidney cancer mid-density tissue array, non-overlapping with KIC1502, 75 cases_150 cores 225-Eur US Biomax tissue
KIC1501 Kidney cancer mid-density tissue array, non-overlapping with KIC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
KIC1502 Kidney cancer mid-density tissue array, non-overlapping with KIC1501, 75 cases_150 cores 225-Eur US Biomax tissue
KIC1502 Kidney cancer mid-density tissue array, non-overlapping with KIC1501, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax tissue
KIC241 Kidney cancer tissue array, 12 cases_24 cores 166-Eur US Biomax tissue
KIC241 Kidney cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
KIC481 Kidney cancer and normal tissue array, 16 cases_48 cores 189-Eur US Biomax tissue
KIC481 Kidney cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin 205-Eur US Biomax tissue
KIC961 Kidney cancer and normal tissue array, non-overlapping with KIC962, 48 cases_96 cores 225-Eur US Biomax elisa
KIC961 Kidney cancer and normal tissue array, non-overlapping with KIC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin 238-Eur US Biomax elisa
KIC962 Kidney cancer and normal tissue array, non-overlapping with KIC961, 48 cases_96 cores 225-Eur US Biomax elisa
KIC962 Kidney cancer and normal tissue array, non-overlapping with KIC961, 48 cases_96 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin 238-Eur US Biomax elisa
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases_100 cores 231-Eur US Biomax tissue
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases_100 cores, replaced by LC10010a; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases_100 cores, replacing LC10010; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC10011 Non-small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores 231-Eur US Biomax tissue
LC10011 Non-small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
LC10012 Lung non-small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases_100 cores, replacing LC1006 266-Eur US Biomax tissue
LC10012 Lung non-small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases_100 cores, replacing LC1006; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases_100 cores, replacing LC1002 266-Eur US Biomax tissue
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases_100 cores, replacing LC1002; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
LC1002 Lung adenocarcinoma (grade II-III) tissue array with self-matched adjacent normal tissue, and 4 non-cancer normal lung tissue, 52 cases_100 cores, replaced by LC10013 231-Eur US Biomax tissue
LC1002 Lung adenocarcinoma (grade II-III) tissue array with self-matched adjacent normal tissue, and 4 non-cancer normal lung tissue, with TNM info, 52 cases_100 cores, replaced by LC10013; ihc Anti-Cytoker 296-Eur US Biomax tissue
LC1004 Lung carcinoma (multi-tissue combined panel) tissue array, 50 cases_100 cores 231-Eur US Biomax tissue
LC1004 Lung carcinoma (multi-tissue combined panel) tissue array, 50 cases_100 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC1005 Lung carcinoma progression tissue array, 77 cases_100 cores 266-Eur US Biomax tissue
LC1005 Lung carcinoma progression tissue array, 77 cases_100 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC1006 Non-small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases_100 cores, with stage and grade data, replacing LC1001 231-Eur US Biomax tissue
LC1006 Non-small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases_100 cores, with stage and grade data, replacing LC1001; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
LC1007 Lung tuberculosis tissue array with normal tissue, 48 cases_100 cores 231-Eur US Biomax tissue
LC1007 Lung tuberculosis tissue array with normal tissue, 48 cases_100 cores; ihc Anti-Cytokeratin (CK) confirmed 296-Eur US Biomax tissue
LC1008 Non-small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 231-Eur US Biomax
LC1008 Non-small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores 231-Eur US Biomax tissue
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC1201 Lung disease spectrum tissue array, 116 cases_120 cores, with grade and stage information 278-Eur US Biomax tissue
LC1201 Lung disease spectrum tissue array, 116 cases_120 cores, with grade and stage information; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC1501 Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 321-Eur US Biomax tissue
LC1501 Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores 266-Eur US Biomax tissue
LC1501 Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
LC1503 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
LC1921 High density non-small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases_192 cores 456-Eur US Biomax tissue
LC1921 High density non-small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC1922 Middle-advanced stage lung non-small cell carcinoma tissue array, including TNM and pathology grade, 96 cases_192 cores 456-Eur US Biomax elisa
LC1922 Middle-advanced stage lung non-small cell carcinoma tissue array, including TNM and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed 487-Eur US Biomax elisa
LC2001 Lung cancer high-density (192 cases_200 cores) tissue array 397-Eur US Biomax tissue
LC2001 Lung cancer high-density (192 cases_200 cores) tissue array; ihc Anti-Cytokeratin (Low-MW) confirmed 382-Eur US Biomax tissue
LC2081 Multiple lung carcinoma (Non-small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases_208 cores, with stage and grade information 456-Eur US Biomax tissue
LC2081 Multiple lung carcinoma (Non-small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases_208 cores, with stage and grade information; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases_208 cores 456-Eur US Biomax tissue
LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC2082 Multiple lung carcinoma and normal tissue array, 70 cases_208 cores 456-Eur US Biomax tissue
LC2082 Multiple lung carcinoma and normal tissue array, 70 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases_208 cores 456-Eur US Biomax tissue
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
LC2084 High-density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases_208 cores 456-Eur US Biomax tissue
LC2084 High-density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
LC2085a High-density (188 cases_208 cores), multiple types of lung cancer (I-3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue 456-Eur US Biomax tissue
LC2085a High-density (188 cases_208 cores), multiple types of lung cancer (I-3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
LC2085b High-density (208 cores), multiple types of lung cancer (grade 1-3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases_208 cores (duplicate of LC2085a) 456-Eur US Biomax tissue
LC2085b High-density (208 cores), multiple types of lung cancer (grade 1-3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases_208 cores (duplicate of LC2085a); ihc Anti-Cy 487-Eur US Biomax tissue
LC2086 Normal lung tissue array, 104 cases_208 cores 456-Eur US Biomax tissue
LC2086 Normal lung tissue array, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed 429-Eur US Biomax tissue
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores 456-Eur US Biomax tissue
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Cytokeratin (CK) confirmed 429-Eur US Biomax tissue
LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases_216 cores 456-Eur US Biomax tissue
LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases_216 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LC241 Non-small cell lung carcinoma (NSCLC) test tissue array, with self-matching normal adjacent tissue, 6 cases_24 cores 88-Eur US Biomax assays
LC241 Non-small cell lung carcinoma (NSCLC) test tissue array, with self-matching normal adjacent tissue, 6 cases_24 cores; ihc Anti-Cytokeratin (High MW) confirmed 90-Eur US Biomax assays
LC242 Non-small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases_24 cores 88-Eur US Biomax assays
LC242 Non-small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases_24 cores; ihc Anti-Cytokeratin (High MW) confirmed 90-Eur US Biomax assays
LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores 189-Eur US Biomax tissue
LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
LC481 Tissue array of lung carcinoma and matched adjacent tissue, 12 cases_48 cores 160-Eur US Biomax tissue
LC481 Tissue array of lung carcinoma and matched adjacent tissue, 12 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC482 Non-small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases_48 cores, with grade and stage status 160-Eur US Biomax tissue
LC482 Non-small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases_48 cores, with grade and stage status; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
LC483 Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores 160-Eur US Biomax tissue
LC483 Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases_48 cores 231-Eur US Biomax tissue
LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases_48 cores 189-Eur US Biomax tissue
LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed 210-Eur US Biomax tissue
LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases_48 cores 188-Eur US Biomax tissue
LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases_48 cores 160-Eur US Biomax tissue
LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases_48 cores 225-Eur US Biomax tissue
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases_48 cores 189-Eur US Biomax tissue
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LC501 Tissue array of multi-type lung cancer and normal tissue with TNM and grade, 50 cases_50 cores 160-Eur US Biomax tissue
LC501 Tissue array of multi-type lung cancer and normal tissue with TNM and grade, 50 cases_50 cores; ihc Anti-Cytokeratin (CK) confirmed 210-Eur US Biomax tissue
LC601 Non-small cell lung carcinoma (NSCLC) and normal tissue array, 25 cases plus normal tissues, with TNM data ----Eur US Biomax tissue
LC6161 High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases_616 cores 753-Eur US Biomax tissue
LC6161 High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases_616 cores; ihc Anti-Actin confirmed 811-Eur US Biomax tissue
LC641 Non-small cell lung carcinoma (NSCLC) tissue array, 64 cases_66 cores, with TNM data ----Eur US Biomax tissue
LC721 Non-small cell lung carcinoma (NSCLC) tissue array, 24 cases_72 cores, replacing BC04011 231-Eur US Biomax tissue
LC721 Non-small cell lung carcinoma (NSCLC) tissue array, 24 cases_72 cores, replacing BC04011; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC722 Lung cancer and normal tissue array, with TNM and grade data, 24 cases_72 cores 231-Eur US Biomax tissue
LC722 Lung cancer and normal tissue array, with TNM and grade data, 24 cases_72 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases_72 cores, replacing BS04071 231-Eur US Biomax tissue
LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases_72 cores, replacing BS04071; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases_72 cores, replacing BS04031 231-Eur US Biomax tissue
LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases_72 cores, replacing BS04031; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC725 Normal lung tissue array, 24 cases_72 cores, replacing BN04011 278-Eur US Biomax tissue
LC725 Normal lung tissue array, 24 cases_72 cores, replacing BN04011; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC04016 231-Eur US Biomax tissue
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replaced by LC726a; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing LC726; ihc Anti-Actin confirmed 228-Eur US Biomax tissue
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases_72 cores 231-Eur US Biomax tissue
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases_72 cores; ihc Anti-Epithelial Membrane Antigen (EMA) confirmed 267-Eur US Biomax tissue
LC801 Lung carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores 189-Eur US Biomax tissue
LC801 Lung carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 185-Eur US Biomax tissue
LC802 Lung small cell carcinoma tissue array (40 cases_80 cores) 266-Eur US Biomax tissue
LC802 Lung small cell carcinoma tissue array, with normal lung tissue, 40 cases_80 cores; ihc Anti-Chromogranin A (CgA) confirmed 228-Eur US Biomax tissue
LC803 Lung carcinoma (multi-tissue combined panel, 80 cases_80 cores) tissue array 231-Eur US Biomax tissue
LC803 Lung carcinoma (multi-tissue combined panel, 80 cases_80 cores) tissue array; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC805 Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases_80 cores 231-Eur US Biomax tissue
LC805 Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 228-Eur US Biomax tissue
LC806 Multiple types of lung carcinoma tissue array, 80 cases_80 cores, replacing BC04013 231-Eur US Biomax tissue
LC806 Multiple types of lung carcinoma tissue array, 80 cases_80 cores, replacing BC04013; ihc Anti-Cytokeratin (CK) confirmed 228-Eur US Biomax tissue
LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases_80 cores, replacing BC04014 231-Eur US Biomax tissue
LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases_80 cores, replacing BC04014; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC808 Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases_80 cores, replacing BS04011 231-Eur US Biomax tissue
LC808 Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases_80 cores, replacing BS04011; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases_80 cores 231-Eur US Biomax tissue
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC810 Lung cancer with matched lymph node metastasis tissue array, 40 cases_80 cores 231-Eur US Biomax tissue
LC810 Lung cancer with matched lymph node metastasis tissue array, 40 cases_80 cores, replaced by LC814; ihc Anti-Cytokeratin (High MW) confirmed 296-Eur US Biomax tissue
LC811 Lung cancer tissue array with normal tissues, 80 cases_80 cores 278-Eur US Biomax tissue
LC811 Lung cancer tissue array with normal tissues, 80 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC812 Lung cancer tissue array with normal tissues from autopsy, with TNM data, 40 cases_80 cores 231-Eur US Biomax tissue
LC812 Lung cancer tissue array with normal tissues from autopsy, with TNM data, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC813 Multiple non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases_80 cores, replacing BC04014 231-Eur US Biomax tissue
LC813 Multiple non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases_80 cores, replacing BC04014; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC814 Lung cancer with matched lymph node metastasis tissue array, 40 cases_80 cores 231-Eur US Biomax tissue
LC814 Lung cancer with matched lymph node metastasis tissue array, 40 cases_80 cores, replacing LC810; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC815 Lung cancer and normal tissue array with stage and grade info, 40 cases_80 cores 231-Eur US Biomax tissue
LC815 Lung cancer and normal tissue array with stage and grade info, 40 cases_80 cores; ihc Anti-Actin confirmed 267-Eur US Biomax tissue
LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores 231-Eur US Biomax tissue
LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed 296-Eur US Biomax tissue
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed 258-Eur US Biomax tissue
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases_95 cores 456-Eur US Biomax tissue
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases_95 cores; ihc Anti-Cytokeratin (CK) confirmed 487-Eur US Biomax tissue
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
LC962 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed 258-Eur US Biomax elisa
LC991 Lung squamous cell carcinoma (grade I-III) tissue array with matched tumor adjacent and normal control, 33 cases_99 cores 231-Eur US Biomax tissue
LC991 Lung squamous cell carcinoma (grade I-III) tissue array with matched tumor adjacent and normal control, 33 cases_99 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LC992 Lung adenocarcinoma (grade I-III, 33 cases) tissue array with matched tumor adjacent and normal control, 33 cases_99 cores 231-Eur US Biomax tissue
LC992 Lung adenocarcinoma (grade I-III, 33 cases) tissue array with matched tumor adjacent and normal control, 33 cases_99 cores; ihc Anti-Cytokeratin (CK) confirmed 267-Eur US Biomax tissue
LM208 High density tissue microarray of Hodgkin's Disease, Non-Hodgkin's lymphoma and normal lymph node tissues, 69 cases_208 cores 456-Eur US Biomax tissue
LM208 High density tissue microarray of Hodgkin's Disease, Non-Hodgkin's lymphoma and normal lymph node tissues, 69 cases_208 cores; ihc Anti-Actin confirmed 487-Eur US Biomax tissue
LM241 Multiple lymphoma tissue array with normal tissues, 12 cases_24 cores 88-Eur US Biomax tissue
LM241 Multiple lymphoma tissue array with normal tissues, 12 cases_24 cores; ihc Anti-CD20 confirmed 105-Eur US Biomax tissue
LM481 Multiple lymphoma tissue array with normal tissues, 48 cases_48 cores 160-Eur US Biomax tissue
LM481 Multiple lymphoma tissue array with normal tissues, 48 cases_48 cores; ihc Anti-Actin confirmed 185-Eur US Biomax tissue
LM482